Alomone 公司是一家位于耶路撒冷的以色列的生物科技公司,专著于提供生命科学细胞生物学试剂和服务。Alomone 公司作为世界上的离子通道专业供应商,它的离子通道抗体是世界上全的、质量也非常好!目前被世界各地的科学家广泛的使用。
Alomone2019年价格表
货号 | 品名 | 规格 | 价格 |
A-105 | A Potent and Selective Inhibitor of the TTX-Resistant NaV1.8 Channel | 10 mg | 629 |
A-105 | A Potent and Selective Inhibitor of the TTX-Resistant NaV1.8 Channel | 25 mg | 1615 |
A-105 | A Potent and Selective Inhibitor of the TTX-Resistant NaV1.8 Channel | 50 mg | 2924 |
A-105 | A Potent and Selective Inhibitor of the TTX-Resistant NaV1.8 Channel | 100 mg | 5389 |
A-110 | A Potent Blocker of L-type and T-type CaV Channels | 250 mg | 629 |
A-110 | A Potent Blocker of L-type and T-type CaV Channels | 1 g | 799 |
A-110 | A Potent Blocker of L-type and T-type CaV Channels | 5 g | 1649 |
A-110 | A Potent Blocker of L-type and T-type CaV Channels | 10 g | 2329 |
A-115 | A Non-specific K+ Channel Blocker | 25 g | 510 |
A-115 | A Non-specific K+ Channel Blocker | 100 g | 1258 |
A-120 | A Potent Blocker of L-type and T-type CaV Channels | 10 mg | 408 |
A-120 | A Potent Blocker of L-type and T-type CaV Channels | 25 mg | 510 |
A-120 | A Potent Blocker of L-type and T-type CaV Channels | 50 mg | 697 |
A-120 | A Potent Blocker of L-type and T-type CaV Channels | 100 mg | 1071 |
A-120 | A Potent Blocker of L-type and T-type CaV Channels | 500 mg | 1479 |
A-120 | A Potent Blocker of L-type and T-type CaV Channels | 1 g | 1819 |
A-120 | A Potent Blocker of L-type and T-type CaV Channels | 5 g | 5559 |
A-135 | A Potent Blocker of L-type CaV Channels | 5 mg | 697 |
A-135 | A Potent Blocker of L-type CaV Channels | 10 mg | 884 |
A-135 | A Potent Blocker of L-type CaV Channels | 25 mg | 1632 |
A-135 | A Potent Blocker of L-type CaV Channels | 50 mg | 2941 |
A-140 | Blocker of ENaC/ASIC/Degenerin Channels | 1 g | 510 |
A-140 | Blocker of ENaC/ASIC/Degenerin Channels | 5 g | 2193 |
A-140 | Blocker of ENaC/ASIC/Degenerin Channels | 10 g | 3876 |
A-145 | A Local Anesthetic, NaV Channel Blocker | 1 g | 323 |
A-145 | A Local Anesthetic, NaV Channel Blocker | 5 g | 510 |
A-150 | An Activator of NaV Channels | 25 mg | 459 |
A-150 | An Activator of NaV Channels | 50 mg | 833 |
A-150 | An Activator of NaV Channels | 100 mg | 1479 |
A-150 | An Activator of NaV Channels | 250 mg | 2941 |
A-155 | A Blocker of L-type CaV Channels an Antagonist of 5-HT2 Serotonin Receptors and an Agonist of α-Adrenoceptors | 10 g | 510 |
A-155 | A Blocker of L-type CaV Channels an Antagonist of 5-HT2 Serotonin Receptors and an Agonist of α-Adrenoceptors | 25 g | 884 |
A-155 | A Blocker of L-type CaV Channels an Antagonist of 5-HT2 Serotonin Receptors and an Agonist of α-Adrenoceptors | 100 g | 3128 |
A-165 | A Negative Allosteric Modulator of GABA(A) Receptors | 1 mg | 799 |
A-165 | A Negative Allosteric Modulator of GABA(A) Receptors | 5 mg | 1649 |
A-165 | A Negative Allosteric Modulator of GABA(A) Receptors | 10 mg | 2329 |
A-165 | A Negative Allosteric Modulator of GABA(A) Receptors | 25 mg | 4641 |
A-180 | A Blocker of TRPV1 Channel | 5 mg | 697 |
A-180 | A Blocker of TRPV1 Channel | 10 mg | 884 |
A-180 | A Blocker of TRPV1 Channel | 25 mg | 2006 |
A-180 | A Blocker of TRPV1 Channel | 50 mg | 3706 |
A-190 | An Activator of TRPV1 Channels and a Ligand of CB1 Cannabinoid Receptors | 5 mg | 510 |
A-190 | An Activator of TRPV1 Channels and a Ligand of CB1 Cannabinoid Receptors | 10 mg | 697 |
A-190 | An Activator of TRPV1 Channels and a Ligand of CB1 Cannabinoid Receptors | 25 mg | 1632 |
A-190 | An Activator of TRPV1 Channels and a Ligand of CB1 Cannabinoid Receptors | 50 mg | 2754 |
A-195 | A Blocker of TRPV1 Channels | 1 mg | 1139 |
A-195 | A Blocker of TRPV1 Channels | 5 mg | 2567 |
A-195 | A Blocker of TRPV1 Channels | 10 mg | 3502 |
A-195 | A Blocker of TRPV1 Channels | 25 mg | 7990 |
A-195 | A Blocker of TRPV1 Channels | 50 mg | 14688 |
A-205 | A Blocker of 5-HT3 Channels | 5 mg | 935 |
A-205 | A Blocker of 5-HT3 Channels | 10 mg | 1479 |
A-205 | A Blocker of 5-HT3 Channels | 25 mg | 3349 |
A-205 | A Blocker of 5-HT3 Channels | 50 mg | 6069 |
A-215 | A Selective Antagonist of TrkB Receptor | 5 mg | 799 |
A-215 | A Selective Antagonist of TrkB Receptor | 10 mg | 1139 |
A-215 | A Selective Antagonist of TrkB Receptor | 25 mg | 2601 |
A-215 | A Selective Antagonist of TrkB Receptor | 50 mg | 4675 |
A-215 | A Selective Antagonist of TrkB Receptor | 100 mg | 8415 |
A-225 | A Blocker of TRPA1 Channels | 5 mg | 629 |
A-225 | A Blocker of TRPA1 Channels | 10 mg | 799 |
A-225 | A Blocker of TRPA1 Channels | 25 mg | 1309 |
A-225 | A Blocker of TRPA1 Channels | 50 mg | 2329 |
A-225 | A Blocker of TRPA1 Channels | 100 mg | 4029 |
A-225 | A Blocker of TRPA1 Channels | 250 mg | 8058 |
A-235 | An Antagonist of 5-HT3A and 5-HT3B Receptors | 5 mg | 459 |
A-235 | An Antagonist of 5-HT3A and 5-HT3B Receptors | 10 mg | 629 |
A-235 | An Antagonist of 5-HT3A and 5-HT3B Receptors | 25 mg | 1139 |
A-235 | An Antagonist of 5-HT3A and 5-HT3B Receptors | 50 mg | 1989 |
A-236 | An Antagonist of 5-HT3A and 5-HT3B Receptors | 10 mg | 459 |
A-236 | An Antagonist of 5-HT3A and 5-HT3B Receptors | 25 mg | 1054 |
A-236 | An Antagonist of 5-HT3A and 5-HT3B Receptors | 50 mg | 1921 |
A-240 | A Potent and Selective blocker of 5-HT3A Channels | 5 mg | 1479 |
A-240 | A Potent and Selective blocker of 5-HT3A Channels | 10 mg | 2499 |
A-240 | A Potent and Selective blocker of 5-HT3A Channels | 25 mg | 5644 |
A-240 | A Potent and Selective blocker of 5-HT3A Channels | 50 mg | 10149 |
A-245 | An Antagonist of Angiotensin II Receptor Type-1 | 10 mg | 459 |
A-245 | An Antagonist of Angiotensin II Receptor Type-1 | 50 mg | 629 |
A-245 | An Antagonist of Angiotensin II Receptor Type-1 | 100 mg | 1139 |
A-245 | An Antagonist of Angiotensin II Receptor Type-1 | 250 mg | 2159 |
A-245 | An Antagonist of Angiotensin II Receptor Type-1 | 500 mg | 3009 |
A-245 | An Antagonist of Angiotensin II Receptor Type-1 | 1 g | 4981 |
A-250 | A Reversible TRPA1 Channel Blocker | 5 mg | 629 |
A-250 | A Reversible TRPA1 Channel Blocker | 10 mg | 799 |
A-250 | A Reversible TRPA1 Channel Blocker | 25 mg | 1819 |
A-250 | A Reversible TRPA1 Channel Blocker | 50 mg | 3349 |
A-260 | A Blocker of NaV Channels, GABA(A) Receptors and an Inhibitor of TrkB Receptor | 1 g | 459 |
A-260 | A Blocker of NaV Channels, GABA(A) Receptors and an Inhibitor of TrkB Receptor | 5 g | 2159 |
A-260 | A Blocker of NaV Channels, GABA(A) Receptors and an Inhibitor of TrkB Receptor | 10 g | 2839 |
A-265 | An Agonist of AMPA Receptors | 5 mg | 1139 |
A-265 | An Agonist of AMPA Receptors | 10 mg | 1479 |
A-265 | An Agonist of AMPA Receptors | 25 mg | 3349 |
A-265 | An Agonist of AMPA Receptors | 50 mg | 6069 |
A-266 | An Agonist of AMPA Receptors | 1 mg | 629 |
A-266 | An Agonist of AMPA Receptors | 5 mg | 1479 |
A-266 | An Agonist of AMPA Receptors | 10 mg | 2159 |
A-266 | An Agonist of AMPA Receptors | 25 mg | 4845 |
A-266 | An Agonist of AMPA Receptors | 50 mg | 8721 |
A-267 | An Agonist of AMPA Receptors | 1 mg | 629 |
A-267 | An Agonist of AMPA Receptors | 5 mg | 1139 |
A-267 | An Agonist of AMPA Receptors | 10 mg | 1989 |
A-267 | An Agonist of AMPA Receptors | 25 mg | 4471 |
A-267 | An Agonist of AMPA Receptors | 50 mg | 8041 |
A-280 | An Agonist of NMDA Receptors | 5 mg | 1479 |
A-280 | An Agonist of NMDA Receptors | 10 mg | 2329 |
A-280 | An Agonist of NMDA Receptors | 25 mg | 5219 |
A-281 | An Agonist of NMDA Receptors | 5 mg | 799 |
A-281 | An Agonist of NMDA Receptors | 10 mg | 1139 |
A-281 | An Agonist of NMDA Receptors | 25 mg | 2601 |
A-281 | An Agonist of NMDA Receptors | 50 mg | 4709 |
A-285 | An Antagonist of NMDA Receptors | 25 mg | 629 |
A-285 | An Antagonist of NMDA Receptors | 50 mg | 799 |
A-285 | An Antagonist of NMDA Receptors | 100 mg | 1479 |
A-300 | A Blocker of TRPA1, TRPV1 and TRPM8 Channels | 5 mg | 1309 |
A-300 | A Blocker of TRPA1, TRPV1 and TRPM8 Channels | 10 mg | 1819 |
A-300 | A Blocker of TRPA1, TRPV1 and TRPM8 Channels | 25 mg | 3349 |
A-300 | A Blocker of TRPA1, TRPV1 and TRPM8 Channels | 50 mg | 4709 |
A-305 | A Blocker of TRPM8 Channels | 5 mg | 629 |
A-305 | A Blocker of TRPM8 Channels | 10 mg | 1139 |
A-305 | A Blocker of TRPM8 Channels | 25 mg | 2499 |
A-305 | A Blocker of TRPM8 Channels | 50 mg | 4029 |
A-330 | An Antagonist of AMPA/Kainate Receptors | 5 mg | 4029 |
A-330 | An Antagonist of AMPA/Kainate Receptors | 10 mg | 7259 |
A-330 | An Antagonist of AMPA/Kainate Receptors | 25 mg | 16269 |
A-335 | An Agonist of TRPV1 Channels and a Ligand of CB1 Receptors | 10 mg | 459 |
A-335 | An Agonist of TRPV1 Channels and a Ligand of CB1 Receptors | 25 mg | 1071 |
A-335 | An Agonist of TRPV1 Channels and a Ligand of CB1 Receptors | 50 mg | 1989 |
A-335 | An Agonist of TRPV1 Channels and a Ligand of CB1 Receptors | 100 mg | 3519 |
A-340 | A Potent and Selective Blocker of TRPM8 Channels | 5 mg | 2329 |
A-340 | A Potent and Selective Blocker of TRPM8 Channels | 10 mg | 3689 |
A-340 | A Potent and Selective Blocker of TRPM8 Channels | 25 mg | 7429 |
A-340 | A Potent and Selective Blocker of TRPM8 Channels | 50 mg | 10999 |
A-345 | A Potent Blocker of TRPV1 Channel | 5 mg | 1139 |
A-345 | A Potent Blocker of TRPV1 Channel | 10 mg | 1989 |
A-345 | A Potent Blocker of TRPV1 Channel | 25 mg | 4471 |
A-345 | A Potent Blocker of TRPV1 Channel | 50 mg | 6001 |
A-350 | An Antagonist of Endothelin Receptors | 5 mg | 2329 |
A-350 | An Antagonist of Endothelin Receptors | 10 mg | 4029 |
A-350 | An Antagonist of Endothelin Receptors | 25 mg | 7259 |
A-350 | An Antagonist of Endothelin Receptors | 50 mg | 11441 |
A-355 | A Selective Antagonist of Endothelin A Receptors | 5 mg | 799 |
A-355 | A Selective Antagonist of Endothelin A Receptors | 10 mg | 1139 |
A-355 | A Selective Antagonist of Endothelin A Receptors | 25 mg | 2601 |
A-355 | A Selective Antagonist of Endothelin A Receptors | 50 mg | 4709 |
A-360 | A Selective Antagonist of the ETB Endothelin Receptors | 1 mg | 1649 |
A-360 | A Selective Antagonist of the ETB Endothelin Receptors | 5 mg | 5899 |
A-360 | A Selective Antagonist of the ETB Endothelin Receptors | 10 mg | 9129 |
A-360 | A Selective Antagonist of the ETB Endothelin Receptors | 25 mg | 16099 |
A-370 | A Positive Modulator of GABA(A) Receptors | 5 mg | 629 |
A-370 | A Positive Modulator of GABA(A) Receptors | 10 mg | 799 |
A-370 | A Positive Modulator of GABA(A) Receptors | 25 mg | 1819 |
A-370 | A Positive Modulator of GABA(A) Receptors | 50 mg | 3281 |
A-375 | A Potent and Selective Antagonist of P2X3 Receptor | 5 mg | 1139 |
A-375 | A Potent and Selective Antagonist of P2X3 Receptor | 10 mg | 1989 |
A-375 | A Potent and Selective Antagonist of P2X3 Receptor | 25 mg | 4471 |
A-375 | A Potent and Selective Antagonist of P2X3 Receptor | 50 mg | 8041 |
A-380 | A Selective Antagonist of P2X3 and P2X2/3 Receptors | 5 mg | 1139 |
A-380 | A Selective Antagonist of P2X3 and P2X2/3 Receptors | 10 mg | 1819 |
A-380 | A Selective Antagonist of P2X3 and P2X2/3 Receptors | 25 mg | 4131 |
A-380 | A Selective Antagonist of P2X3 and P2X2/3 Receptors | 50 mg | 6409 |
A-385 | An Agonist of P2X7 Receptors | 5 mg | 1139 |
A-385 | An Agonist of P2X7 Receptors | 10 mg | 1989 |
A-385 | An Agonist of P2X7 Receptors | 25 mg | 3519 |
A-390 | A Selective and Potent Antagonist of mGluR1 Receptors | 5 mg | 1649 |
A-390 | A Selective and Potent Antagonist of mGluR1 Receptors | 10 mg | 2329 |
A-390 | A Selective and Potent Antagonist of mGluR1 Receptors | 25 mg | 4641 |
A-390 | A Selective and Potent Antagonist of mGluR1 Receptors | 50 mg | 8381 |
A-395 | A Potent and Selective Antagonist of Human P2X7 Receptors | 5 mg | 1139 |
A-395 | A Potent and Selective Antagonist of Human P2X7 Receptors | 10 mg | 1989 |
A-395 | A Potent and Selective Antagonist of Human P2X7 Receptors | 25 mg | 4471 |
A-395 | A Potent and Selective Antagonist of Human P2X7 Receptors | 50 mg | 8041 |
A-400 | A Potent Activator of NaV Channels | 5 µg | 1836 |
A-400 | A Potent Activator of NaV Channels | 5 x 5 µg | 7327 |
A-400 | A Potent Activator of NaV Channels | 10 µg | 2380 |
A-400 | A Potent Activator of NaV Channels | 5 x 10 µg | 9503 |
A-400 | A Potent Activator of NaV Channels | 0.1 mg | 8891 |
A-405 | A Potent and Selective Antagonist of P2X7 Receptors | 5 mg | 1139 |
A-405 | A Potent and Selective Antagonist of P2X7 Receptors | 10 mg | 1649 |
A-405 | A Potent and Selective Antagonist of P2X7 Receptors | 25 mg | 3689 |
A-405 | A Potent and Selective Antagonist of P2X7 Receptors | 50 mg | 6681 |
A-410 | A Potent and Selective Antagonist of P2X7 Receptors | 5 mg | 1649 |
A-410 | A Potent and Selective Antagonist of P2X7 Receptors | 10 mg | 2839 |
A-410 | A Potent and Selective Antagonist of P2X7 Receptors | 25 mg | 6239 |
A-410 | A Potent and Selective Antagonist of P2X7 Receptors | 50 mg | 9639 |
A-415 | A Potent and Selective Antagonist of P2X7 Receptors | 5 mg | 629 |
A-415 | A Potent and Selective Antagonist of P2X7 Receptors | 10 mg | 799 |
A-415 | A Potent and Selective Antagonist of P2X7 Receptors | 25 mg | 1819 |
A-415 | A Potent and Selective Antagonist of P2X7 Receptors | 50 mg | 3281 |
A-420 | A Potent and Selective Antagonist of P2X7 Receptors | 10 mg | 459 |
A-420 | A Potent and Selective Antagonist of P2X7 Receptors | 25 mg | 629 |
A-420 | A Potent and Selective Antagonist of P2X7 Receptors | 50 mg | 799 |
A-420 | A Potent and Selective Antagonist of P2X7 Receptors | 100 mg | 1649 |
A-425 | A Potent and Selective Antagonist of P2X7 Receptors | 1 mg | 799 |
A-425 | A Potent and Selective Antagonist of P2X7 Receptors | 5 mg | 3009 |
A-425 | A Potent and Selective Antagonist of P2X7 Receptors | 10 mg | 4641 |
A-425 | A Potent and Selective Antagonist of P2X7 Receptors | 25 mg | 9282 |
A-435 | An Antagonist of mGluR1 and mGluR5 | 5 mg | 2329 |
A-435 | An Antagonist of mGluR1 and mGluR5 | 10 mg | 3689 |
A-435 | An Antagonist of mGluR1 and mGluR5 | 25 mg | 6443 |
A-435 | An Antagonist of mGluR1 and mGluR5 | 50 mg | 9078 |
A-440 | An Antagonist of mGluR1 and mGluR5 | 5 mg | 1139 |
A-440 | An Antagonist of mGluR1 and mGluR5 | 10 mg | 1819 |
A-440 | An Antagonist of mGluR1 and mGluR5 | 25 mg | 3689 |
A-440 | An Antagonist of mGluR1 and mGluR5 | 50 mg | 5899 |
A-455 | A Potent and Selective Antagonist of Endothelin A Receptors | 1 mg | 799 |
A-455 | A Potent and Selective Antagonist of Endothelin A Receptors | 5 mg | 2159 |
A-455 | A Potent and Selective Antagonist of Endothelin A Receptors | 10 mg | 2839 |
A-455 | A Potent and Selective Antagonist of Endothelin A Receptors | 25 mg | 6375 |
A-455 | A Potent and Selective Antagonist of Endothelin A Receptors | 50 mg | 10149 |
A-470 | A Potent and Selective Antagonist of P2X7 Receptors | 5 mg | 629 |
A-470 | A Potent and Selective Antagonist of P2X7 Receptors | 10 mg | 1139 |
A-470 | A Potent and Selective Antagonist of P2X7 Receptors | 25 mg | 2499 |
A-470 | A Potent and Selective Antagonist of P2X7 Receptors | 50 mg | 4539 |
A-480 | A Potent and Selective Agonist of GluK1 Kainate Receptor | 5 mg | 1139 |
A-480 | A Potent and Selective Agonist of GluK1 Kainate Receptor | 10 mg | 1649 |
A-480 | A Potent and Selective Agonist of GluK1 Kainate Receptor | 25 mg | 3689 |
A-480 | A Potent and Selective Agonist of GluK1 Kainate Receptor | 50 mg | 6443 |
A-495 | A Potent and Selective Inhibitor of TrkA, TrkB, TrkC Receptors | 5 mg | 2329 |
A-495 | A Potent and Selective Inhibitor of TrkA, TrkB, TrkC Receptors | 10 mg | 3009 |
A-495 | A Potent and Selective Inhibitor of TrkA, TrkB, TrkC Receptors | 25 mg | 6001 |
A-495 | A Potent and Selective Inhibitor of TrkA, TrkB, TrkC Receptors | 50 mg | 9639 |
A-510 | A Non Active Analogue of Ryanodine Receptors | 50 µg | 3502 |
A-520 | Protein Synthesis Inhibitor | 5 mg | 289 |
A-520 | Protein Synthesis Inhibitor | 10 mg | 391 |
A-520 | Protein Synthesis Inhibitor | 25 mg | 799 |
A-520 | Protein Synthesis Inhibitor | 50 mg | 1139 |
A-520 | Protein Synthesis Inhibitor | 100 mg | 2091 |
A-580 | An Anticancer Antibiotic | 0.1 mg | 1836 |
A-580 | An Anticancer Antibiotic | 5 x 0.1 mg | 7327 |
A-600 | Widely Used Ca2+ Ionophore | 1 mg | 510 |
A-600 | Widely Used Ca2+ Ionophore | 10 x 1 mg | 3128 |
A-600 | Widely Used Ca2+ Ionophore | 5 mg | 884 |
A-600 | Widely Used Ca2+ Ionophore | 5 x 5 mg | 3519 |
A-600 | Widely Used Ca2+ Ionophore | 10 mg | 1445 |
A-800 | Immunosuppressant | 0.5 mg | 1258 |
A-800 | Immunosuppressant | 1 mg | 1836 |
AK-100 | A screening package of P2Y Receptor Antibodies economically priced | 22 vials | 34323 |
AK-101 | A screening package of Adrenoceptor Antibodies economically priced | 18 vials | 28084 |
AK-102 | A screening package of Dopamine Receptor Antibodies economically priced | 12 vials | 18717 |
AK-103 | A screening package of mGluR Antibodies economically priced | 18 vials | 28084 |
AK-104 | A screening package of Somatostatin Receptor Antibodies economically priced | 12 vials | 18717 |
AK-105 | A screening package of mGluR Antibodies economically priced | 10 vials | 15606 |
AK-200 | A screening package of Kir Channel Antibodies economically priced | 35 vials | 56151 |
AK-201 | A screening package of P2X Receptor Antibodies economically priced | 28 vials | 43673 |
AK-202 | A screening package of Two-Pore Domain K+ Channel Antibodies economically priced | 28 vials | 43673 |
AK-203 | A screening package of nAChR Antibodies economically priced | 26 vials | 40562 |
AK-204 | A screening package of CNGA Antibodies economically priced | 8 vials | 12478 |
AK-205 | A screening package of HCN Antibodies economically priced | 14 vials | 21845 |
AK-206 | A screening package of Muscarinic Receptor Antibodies economically priced | 12 vials | 18717 |
AK-209 | A screening package of Store-Operated Ca2+ Channel Antibodies economically priced | 19 vials | 31195 |
AK-210 | A screening package of TRPM Channel Antibodies economically priced | 16 vials | 24956 |
AK-211 | A screening package of TRPV Channel Antibodies economically priced | 24 vials | 37434 |
AK-212 | A screening package of TRPC Channe Antibodies economically priced | 24 vials | 37434 |
AK-213 | A screening package of AMPA Receptor Antibodies economically priced | 24 vials | 37434 |
AK-214 | A screening package of NMDA Receptor Antibodies economically priced | 16 vials | 24956 |
AK-215 | A screening package of L-Type CaV Channel Antibodies economically priced | 40 vials | 62390 |
AK-216 | A screening package of Non-L-Type CaV Channel Antibodies economically priced | 38 vials | 59279 |
AK-217 | A screening package of Bkca Channel Antibodies economically priced | 20 vials | 31195 |
AK-218 | A screening package of Non-BKCa Channel Antibodies economically priced | 13 vials | 21845 |
AK-219 | A screening package of Shaker (KV) Channel Antibodies economically priced | 32 vials | 49912 |
AK-220 | A screening package of Shaker (KV)-Related Channel Antibodies economically priced | 34 vials | 53040 |
AK-221 | A screening package of KCNQ Channel Antibodies economically priced | 20 vials | 31195 |
AK-222 | A screening package of hERG and hERG-Related Channel Antibodies economically priced | 18 vials | 28084 |
AK-223 | A screening package of TTX-Resistant NaV Channel Antibodies economically priced | 26 vials | 40562 |
AK-224 | A screening package of TTX-Sensitive NaV Channel Antibodies economically priced | 32 vials | 49912 |
AK-225 | A screening package of Aquaporin Antibodies economically priced | 22 vials | 34323 |
AK-226 | A screening package of ASIC Channel Antibodies economically priced | 16 vials | 24956 |
AK-227 | A screening package of GIRK (Kir3) Channel Antibodies economically priced | 9 vials | 15606 |
AK-228 | A screening package of GABA(A) α Receptor Antibodies economically priced | 14 vials | 21845 |
AK-229 | A screening package of GABA(A) Receptor Antibodies economically priced | 32 vials | 49912 |
AK-230 | A screening package of Glycine Receptor Antibodies economically priced | 8 vials | 12478 |
AK-231 | A screening package of nAChRα Antibodies economically priced | 18 vials | 28084 |
AK-232 | A screening package of nAChRβ Antibodies economically priced | 8 vials | 12478 |
AK-233 | A screening package of Intracellular Ion Channel Antibodies economically priced | 24 vials | 37434 |
AK-234 | A screening package of Mechanosensitive Ion Channel Antibodies economically priced | 32 vials | 49912 |
AK-235 | A screening package of Presynaptic Marker Antibodies economically priced | 36 vials | 56151 |
AK-236 | A screening package of Postsynaptic Marker Antibodies economically priced | 32 vials | 49912 |
AK-237 | A screening package of TASK-Related K2P Channel Antibodies economically priced | 8 vials | 12478 |
AK-238 | A screening package of Neurotrophin Receptor Antibodies economically priced | 12 vials | 18717 |
AK-300 | A Screening Package of Ca2+ ATPase Antibodies Economically Priced | 14 vials | 21845 |
AK-305 | A Screening Package of Mechanosensitive TRP Channel Antibodies for Economically Priced | 18 vials | 28084 |
AK-306 | A Screening Package of Mechanosensitive KCNK (K2P) Channel Antibodies Economically Priced | 10 vials | 15606 |
AK-310 | A Screening Package of Cardiac CaV Channel Antibodies Economically Priced | 14 vials | 21845 |
AK-320 | A Screening Package of Cardiac KV Channel Antibodies Economically Priced | 36 vials | 56151 |
AK-330 | A Screening Package of Cardiac Kir Channel Antibodies Economically Priced | 13 vials | 21845 |
AK-340 | A Screening Package of Cardiac KCNK (K2P) Channel Antibodies Economically Priced | 8 vials | 12478 |
AK-350 | A Screening Package of Long QT Syndrome-Related Antibodies Economically Priced | 18 vials | 28084 |
AK-360 | A Screening Package of CaV Channel Antibodies for Pain Research Economically Priced | 12 vials | 18717 |
AK-365 | A Screening Package of NaV Channel Antibodies for Pain Research Economically Priced | 28 vials | 43673 |
AK-370 | A Screening Package of TRP Channel Antibodies for Pain Research Economically Priced | 22 vials | 34323 |
AK-375 | A Screening Package of nAChR Antibodies for Pain Research Economically Priced | 8 vials | 12478 |
AK-380 | A Screening Package of P2X Receptor Antibodies for Pain Research Economically Priced | 16 vials | 24956 |
AK-385 | A Screening Package of KV Channel Antibodies for Pain Research Economically Priced | 12 vials | 18717 |
AK-390 | A Screening Package of K+ Channel Antibodies for Pain Research Economically Priced | 25 vials | 40562 |
AK-395 | A Screening Package of iGluR Antibodies for Pain Research Economically Priced | 16 vials | 24956 |
AK-400 | A Screening Package of Purinergic Receptor Antibodies for Pain Research Economically Priced | 26 vials | 40562 |
AK-405 | A Screening Package of Ca2+-Activated Cl- Channel Antibodies Economically Priced | 12 vials | 18717 |
AK-410 | A Screening Package of Intracellular Cl- Channel (CLIC) Antibodies Economically Priced | 6 vials | 11237 |
AK-415 | A Screening Package of Voltage-Gated Cl- Channel Antibodies Economically Priced | 12 vials | 18717 |
AK-420 | A Screening Package of Connexin Antibodies for Economically Priced | 16 vials | 24956 |
AK-425 | A Screening Package of Connexin and Pannexin Antibodies for Economically Priced | 22 vials | 34323 |
AK-430 | A Screening Package of Neuronal Adhesion Molecule Antibodies for Economically Priced | 24 vials | 37434 |
AK-435 | A Screening Package of GABA Transporter Antibodies Economically Priced | 14 vials | 21845 |
AK-440 | A Screening Package of Glutamate Transporter Antibodies Economically Priced | 16 vials | 24956 |
AK-445 | A Screening Package of Monoamine Transporter Antibodies Economically Priced | 10 vials | 15606 |
AK-450 | A Screening Package of Nucleoside Transporter Antibodies Economically Priced | 10 vials | 15606 |
AK-455 | A Screening Package of Intracellular Ca2+ Regulator Antibodies Economically Priced | 26 vials | 40562 |
AK-460 | A Screening Package of pH-Sensitive Kir Channel Antibodies Economically Priced | 10 vials | 15606 |
AK-465 | A Screening Package of pH-Sensitive KCNK (K2P) Channel Antibodies Economically Priced | 18 vials | 28084 |
AK-470 | A Screening Package of pH-Sensitive KV Channel Antibodies Economically Priced | 20 vials | 31195 |
AK-475 | A Screening Package of pH-Sensitive TRP Channel Antibodies Economically Priced | 14 vials | 21845 |
AK-480 | A Screening Package of Extracellular-Targeted P2X Receptor Antibodies Economically Priced | 14 vials | 21845 |
AK-485 | A Screening Package of Extracellular-Targeted TRPV Channel Antibodies Economically Priced | 12 vials | 18717 |
AK-490 | A Screening Package of α1-Adrenergic Receptor Antibodies Economically Priced | 6 vials | 11237 |
AK-495 | A Screening Package of α2-Adrenergic Receptor Antibodies Economically Priced | 6 vials | 11237 |
AK-500 | A Screening Package of β-Adrenergic Receptor Antibodies Economically Priced | 6 vials | 11237 |
AK-505 | A Screening Package of Glucagon Receptor Family Antibodies Economically Priced | 8 vials | 12478 |
AK-510 | A Screening Package of Leukotriene Receptor Antibodies Economically Priced | 8 vials | 12478 |
AK-515 | A Screening Package of Lysophospholipid (LPA) Receptor Antibodies Economically Priced | 12 vials | 18717 |
AK-520 | A Screening Package of Opioid Receptor Antibodies Economically Priced | 8 vials | 12478 |
AK-525 | A Screening Package of SNARE Complex Antibodies Economically Priced | 16 vials | 24956 |
AK-530 | A Screening Package of Lysosomal Ion Channel Antibodies Economically Price | 18 vials | 28084 |
AK-535 | A Screening Package of Mitochondrial Ion Channel Antibodies Economically Priced | 31 vials | 49912 |
AK-540 | A Screening Package of Neuropeptide Y Receptor Antibodies Economically Priced | 8 vials | 12478 |
AK-545 | A Screening Package of GPCR Pain-Related Antibodies Economically Priced | 16 vials | 24956 |
AK-550 | A Package of Pain-Related DRG Marker Antibodies Economically Priced | 18 vials | 28084 |
AK-555 | A Screening Package of Kainate Receptor Antibodies Economically Priced | 10 vials | 15606 |
AK-560 | A Screening Package of Histamine Receptor Antibodies Economically Priced | 8 vials | 12478 |
AK-565 | A Screening Package of Melanocortin Receptor Antibodies Economically Priced | 10 vials | 15606 |
AK-570 | A Screening Package of ENaC Antibodies Economically Priced | 6 vials | 11237 |
AK-580 | A Screening Package of Parkinson’s Disease Marker Antibodies Economically Priced | 28 vials | 43673 |
AK-585 | A Screening Package of Serotonin Receptor Antibodies Economically Priced | 14 vials | 21845 |
AK-590 | A Screening Package of Serotonin Signaling Antibodies Economically Priced | 24 vials | 37434 |
AK-595 | A Screening Package of Neuroligin & Neurexin Antibodies Economically Priced | 10 vials | 15606 |
AK-600 | A Screening Package of Nodes of Ranvier Antibodies Economically Priced | 30 vials | 46801 |
AK-605 | A Screening Package of Inflammatory Protein Antibodies Economically Priced | 34 vials | 53040 |
AK-610 | A Screening Package of Na+/H+ Exchanger (NHE) Antibodies Economically Priced | 10 vials | 15606 |
AK-615 | A Screening Package of NMDA Receptor Interacting Protein Antibodies Economically Priced | 22 vials | 34323 |
AK-620 | A Screening Package of Antibodies to SAN Expressing Proteins Economically Priced | 22 vials | 34323 |
B-100 | A Potent Blocker of α7 and Muscle nAChR and GABA(A) Receptor Subtypes | 0.5 mg | 1309 |
B-100 | A Potent Blocker of α7 and Muscle nAChR and GABA(A) Receptor Subtypes | 1 mg | 1649 |
B-100 | A Potent Blocker of α7 and Muscle nAChR and GABA(A) Receptor Subtypes | 5 mg | 5899 |
B-100 | A Potent Blocker of α7 and Muscle nAChR and GABA(A) Receptor Subtypes | 10 mg | 9129 |
B-100 | A Potent Blocker of α7 and Muscle nAChR and GABA(A) Receptor Subtypes | 25 mg | 15929 |
B-100-AG | A Potent Blocker of α7 and Muscle nAChR and GABA(A) Receptor Subtypes Conjugated to the Fluorescent Dye ATTO-488 | 0.1 mg | 2329 |
B-100-AG | A Potent Blocker of α7 and Muscle nAChR and GABA(A) Receptor Subtypes Conjugated to the Fluorescent Dye ATTO-488 | 5 x 0.1 mg | 9316 |
B-100-B | A Potent Blocker of α7 and Muscle nAChR and GABA(A) Receptor Subtypes Conjugated to Biotin | 10 µg | 2329 |
B-100-B | A Potent Blocker of α7 and Muscle nAChR and GABA(A) Receptor Subtypes Conjugated to Biotin | 50 µg | 9316 |
B-100-F | A Potent Blocker of α7 and Muscle nAChR and GABA(A) Receptor Subtypes Conjugated to the Fluorescent Dye FITC | 50 µg | 1139 |
B-100-F | A Potent Blocker of α7 and Muscle nAChR and GABA(A) Receptor Subtypes Conjugated to the Fluorescent Dye FITC | 5 x 50 µg | 4556 |
B-100-F | A Potent Blocker of α7 and Muscle nAChR and GABA(A) Receptor Subtypes Conjugated to the Fluorescent Dye FITC | 10 x 50 µg | 6375 |
B-100-FR | A Potent Blocker of α7 and Muscle nAChR and GABA(A) Receptor Subtypes Conjugated to the Fluorescent Dye ATTO-633 | 0.1 mg | 2329 |
B-100-FR | A Potent Blocker of α7 and Muscle nAChR and GABA(A) Receptor Subtypes Conjugated to the Fluorescent Dye ATTO-633 | 5 x 0.1 mg | 9316 |
B-110 | An Antagonist of TRPV1 Channel | 10 mg | 629 |
B-110 | An Antagonist of TRPV1 Channel | 25 mg | 1411 |
B-110 | An Antagonist of TRPV1 Channel | 50 mg | 2499 |
B-115 | A Selective Antagonist of M1 Muscarinic Acetylcholine Receptors (mAChRs) | 5 mg | 697 |
B-115 | A Selective Antagonist of M1 Muscarinic Acetylcholine Receptors (mAChRs) | 10 mg | 884 |
B-115 | A Selective Antagonist of M1 Muscarinic Acetylcholine Receptors (mAChRs) | 25 mg | 1632 |
B-115 | A Selective Antagonist of M1 Muscarinic Acetylcholine Receptors (mAChRs) | 50 mg | 2941 |
B-120 | A Dihydropyridine Blocker of Voltage-Gated Ca2+ Channels | 5 mg | 459 |
B-120 | A Dihydropyridine Blocker of Voltage-Gated Ca2+ Channels | 10 mg | 629 |
B-120 | A Dihydropyridine Blocker of Voltage-Gated Ca2+ Channels | 25 mg | 799 |
B-120 | A Dihydropyridine Blocker of Voltage-Gated Ca2+ Channels | 50 mg | 1139 |
B-120 | A Dihydropyridine Blocker of Voltage-Gated Ca2+ Channels | 100 mg | 1649 |
B-125 | A State-Dependent Blocker of Neuronal NaV Channels and a Blocker of KCa Channels | 1 g | 697 |
B-125 | A State-Dependent Blocker of Neuronal NaV Channels and a Blocker of KCa Channels | 5 g | 1258 |
B-125 | A State-Dependent Blocker of Neuronal NaV Channels and a Blocker of KCa Channels | 15 g | 2567 |
B-135 | A Potent Antagonist of GABA(A) Receptor Channels | 50 mg | 629 |
B-135 | A Potent Antagonist of GABA(A) Receptor Channels | 100 mg | 799 |
B-135 | A Potent Antagonist of GABA(A) Receptor Channels | 250 mg | 1819 |
B-135 | A Potent Antagonist of GABA(A) Receptor Channels | 500 mg | 3281 |
B-136 | An Antagonist of GABA(A) Receptors | 5 mg | 459 |
B-136 | An Antagonist of GABA(A) Receptors | 10 mg | 629 |
B-136 | An Antagonist of GABA(A) Receptors | 25 mg | 1309 |
B-136 | An Antagonist of GABA(A) Receptors | 50 mg | 1819 |
B-137 | An Antagonist of GABA(A) Receptors | 5 mg | 629 |
B-137 | An Antagonist of GABA(A) Receptors | 10 mg | 799 |
B-137 | An Antagonist of GABA(A) Receptors | 25 mg | 1649 |
B-137 | An Antagonist of GABA(A) Receptors | 50 mg | 2669 |
B-137 | An Antagonist of GABA(A) Receptors | 100 mg | 4743 |
B-140 | An Agonist of D2 Dopamine Receptor and α2-Adrenoceptor and a Blocker of 5-HT3 Channel | 5 mg | 1139 |
B-140 | An Agonist of D2 Dopamine Receptor and α2-Adrenoceptor and a Blocker of 5-HT3 Channel | 10 mg | 1479 |
B-140 | An Agonist of D2 Dopamine Receptor and α2-Adrenoceptor and a Blocker of 5-HT3 Channel | 25 mg | 2499 |
B-140 | An Agonist of D2 Dopamine Receptor and α2-Adrenoceptor and a Blocker of 5-HT3 Channel | 50 mg | 4471 |
B-145 | A Blocker of 5-HT3A and GABA(A) Channels | 10 mg | 629 |
B-145 | A Blocker of 5-HT3A and GABA(A) Channels | 25 mg | 1411 |
B-145 | A Blocker of 5-HT3A and GABA(A) Channels | 50 mg | 2584 |
B-160 | An Inhibitor of Na+/Ca2+ Exchangers and a Blocker of ASIC, TRPP3 and TRPA1 Channels | 10 mg | 629 |
B-160 | An Inhibitor of Na+/Ca2+ Exchangers and a Blocker of ASIC, TRPP3 and TRPA1 Channels | 25 mg | 1258 |
B-160 | An Inhibitor of Na+/Ca2+ Exchangers and a Blocker of ASIC, TRPP3 and TRPA1 Channels | 50 mg | 2091 |
B-161 | An Inhibitor of Na+/Ca2+ Exchangers and a Blocker of ASIC, TRPP3 and TRPA1 Channels | 5 mg | 459 |
B-161 | An Inhibitor of Na+/Ca2+ Exchangers and a Blocker of ASIC, TRPP3 and TRPA1 Channels | 10 mg | 629 |
B-161 | An Inhibitor of Na+/Ca2+ Exchangers and a Blocker of ASIC, TRPP3 and TRPA1 Channels | 25 mg | 1258 |
B-161 | An Inhibitor of Na+/Ca2+ Exchangers and a Blocker of ASIC, TRPP3 and TRPA1 Channels | 50 mg | 2091 |
B-170 | An Antagonist of Endothelin Receptors | 25 mg | 629 |
B-170 | An Antagonist of Endothelin Receptors | 50 mg | 799 |
B-170 | An Antagonist of Endothelin Receptors | 100 mg | 1309 |
B-170 | An Antagonist of Endothelin Receptors | 250 mg | 2669 |
B-175 | A Selective Antagonist of Endothelin B Receptors | 0.5 mg | 1309 |
B-175 | A Selective Antagonist of Endothelin B Receptors | 1 mg | 1819 |
B-175 | A Selective Antagonist of Endothelin B Receptors | 5 mg | 5049 |
B-175 | A Selective Antagonist of Endothelin B Receptors | 10 mg | 6749 |
B-176 | A Selective Antagonist of Endothelin B Receptors | 0.5 mg | 1309 |
B-176 | A Selective Antagonist of Endothelin B Receptors | 1 mg | 1819 |
B-176 | A Selective Antagonist of Endothelin B Receptors | 5 mg | 5049 |
B-176 | A Selective Antagonist of Endothelin B Receptors | 10 mg | 6749 |
B-185 | A Selective Antagonist of Endothelin A Receptors | 5 mg | 1649 |
B-185 | A Selective Antagonist of Endothelin A Receptors | 10 mg | 2839 |
B-185 | A Selective Antagonist of Endothelin A Receptors | 25 mg | 4981 |
B-185 | A Selective Antagonist of Endothelin A Receptors | 50 mg | 7089 |
B-186 | A Selective Antagonist of Endothelin A Receptors | 5 mg | 2329 |
B-186 | A Selective Antagonist of Endothelin A Receptors | 10 mg | 3349 |
B-186 | A Selective Antagonist of Endothelin A Receptors | 25 mg | 5831 |
B-186 | A Selective Antagonist of Endothelin A Receptors | 50 mg | 8041 |
B-240 | Mouse proBrain-Derived Neutrotrophic Factor, Recombinant, <em>E. coli</em> | 2 µg | 629 |
B-240 | Mouse proBrain-Derived Neutrotrophic Factor, Recombinant, <em>E. coli</em> | 5 µg | 1479 |
B-240 | Mouse proBrain-Derived Neutrotrophic Factor, Recombinant, <em>E. coli</em> | 10 µg | 1819 |
B-240 | Mouse proBrain-Derived Neutrotrophic Factor, Recombinant, <em>E. coli</em> | 25 µg | 4199 |
B-240 | Mouse proBrain-Derived Neutrotrophic Factor, Recombinant, <em>E. coli</em> | 50 µg | 7429 |
B-240 | Mouse proBrain-Derived Neutrotrophic Factor, Recombinant, <em>E. coli</em> | 0.1 mg | 14059 |
B-240 | Mouse proBrain-Derived Neutrotrophic Factor, Recombinant, <em>E. coli</em> | 0.25 mg | 25075 |
B-240 | Mouse proBrain-Derived Neutrotrophic Factor, Recombinant, <em>E. coli</em> | 0.5 mg | 39899 |
B-240 | Mouse proBrain-Derived Neutrotrophic Factor, Recombinant, <em>E. coli</em> | 1 mg | 48841 |
B-243 | Mouse proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 2 µg | 629 |
B-243 | Mouse proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 5 µg | 1479 |
B-243 | Mouse proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 10 µg | 1819 |
B-243 | Mouse proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 25 µg | 4199 |
B-243 | Mouse proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 50 µg | 7429 |
B-243 | Mouse proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 0.1 mg | 14059 |
B-243 | Mouse proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 0.25 mg | 25075 |
B-243 | Mouse proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 0.5 mg | 39899 |
B-243 | Mouse proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 1 mg | 48841 |
B-245 | Human Brain-Derived Neurotrophic Factor proDomain, Recombinant, <em>E. coli</em> | 10 µg | 2329 |
B-245 | Human Brain-Derived Neurotrophic Factor proDomain, Recombinant, <em>E. coli</em> | 25 µg | 4029 |
B-245 | Human Brain-Derived Neurotrophic Factor proDomain, Recombinant, <em>E. coli</em> | 50 µg | 5729 |
B-245 | Human Brain-Derived Neurotrophic Factor proDomain, Recombinant, <em>E. coli</em> | 0.1 mg | 8041 |
B-245 | Human Brain-Derived Neurotrophic Factor proDomain, Recombinant, <em>E. coli</em> | 0.5 mg | 28509 |
B-250 | Human Brain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 1 µg | 629 |
B-250 | Human Brain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 5 x 1 µg | 2516 |
B-250 | Human Brain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 5 µg | 1819 |
B-250 | Human Brain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 10 µg | 1989 |
B-250 | Human Brain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 25 µg | 4471 |
B-250 | Human Brain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 50 µg | 8041 |
B-250 | Human Brain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 0.1 mg | 12801 |
B-250 | Human Brain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 0.25 mg | 26129 |
B-250 | Human Brain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 0.5 mg | 41701 |
B-250 | Human Brain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 1 mg | 66929 |
B-250-B | A Biotin Labeled Human Brain-Derived Neurotrophic Factor | 2 µg | 8891 |
B-250-B | A Biotin Labeled Human Brain-Derived Neurotrophic Factor | 5 x 2 µg | 35530 |
B-250-B | A Biotin Labeled Human Brain-Derived Neurotrophic Factor | 5 µg | 13940 |
B-256 | Human proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 2 µg | 629 |
B-256 | Human proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 5 µg | 1479 |
B-256 | Human proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 10 µg | 1819 |
B-256 | Human proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 25 µg | 4199 |
B-256 | Human proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 50 µg | 7429 |
B-256 | Human proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 0.1 mg | 14059 |
B-256 | Human proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 0.25 mg | 25075 |
B-256 | Human proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 0.5 mg | 39899 |
B-256 | Human proBrain-Derived Neurotrophic Factor (cleavage resistant), Recombinant, <em>E. coli</em> | 1 mg | 48841 |
B-256-B | Human proBrain-Derived Neurotrophic Factor Conjugated to Biotin | 1 µg | 2329 |
B-256-B | Human proBrain-Derived Neurotrophic Factor Conjugated to Biotin | 10 µg | 7429 |
B-256-B | Human proBrain-Derived Neurotrophic Factor Conjugated to Biotin | 50 µg | 14875 |
B-257 | Human proBrain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 5 µg | 1139 |
B-257 | Human proBrain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 10 µg | 1479 |
B-257 | Human proBrain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 25 µg | 3349 |
B-257 | Human proBrain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 50 µg | 4879 |
B-257 | Human proBrain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 0.1 mg | 8789 |
B-257 | Human proBrain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 0.25 mg | 19839 |
B-257 | Human proBrain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 0.5 mg | 24259 |
B-257 | Human proBrain-Derived Neurotrophic Factor, Recombinant, <em>E. coli</em> | 1 mg | 31229 |
B-275 | Protein Synthesis and Transport Inhibitor | 1 mg | 697 |
B-275 | Protein Synthesis and Transport Inhibitor | 5 x 1 mg | 2771 |
B-350 | A Voltage Gated Ca2+ Channel Activator | 5 mg | 629 |
B-350 | A Voltage Gated Ca2+ Channel Activator | 10 mg | 799 |
B-350 | A Voltage Gated Ca2+ Channel Activator | 25 mg | 1649 |
B-350 | A Voltage Gated Ca2+ Channel Activator | 50 mg | 2669 |
B-350 | A Voltage Gated Ca2+ Channel Activator | 100 mg | 4301 |
B-351 | An Activator of L-Type CaV Channels | 1 mg | 799 |
B-351 | An Activator of L-Type CaV Channels | 5 mg | 1649 |
B-351 | An Activator of L-Type CaV Channels | 10 mg | 2329 |
B-351 | An Activator of L-Type CaV Channels | 25 mg | 4658 |
B-351 | An Activator of L-Type CaV Channels | 50 mg | 7429 |
B-351 | An Activator of L-Type CaV Channels | 100 mg | 11849 |
B-352 | A Blocker of L-Type CaV Channels | 1 mg | 799 |
B-352 | A Blocker of L-Type CaV Channels | 5 mg | 1649 |
B-352 | A Blocker of L-Type CaV Channels | 10 mg | 2329 |
B-352 | A Blocker of L-Type CaV Channels | 25 mg | 4658 |
B-352 | A Blocker of L-Type CaV Channels | 50 mg | 7429 |
B-352 | A Blocker of L-Type CaV Channels | 100 mg | 11849 |
B-445 | Neurotrophic Factor | 10 µg | 2567 |
B-445 | Neurotrophic Factor | 5 X 10 µg | 10251 |
B-450 | A Specific Blocker of KV3 Channels | 0.1 mg | 4029 |
B-450 | A Specific Blocker of KV3 Channels | 0.5 mg | 10999 |
B-450 | A Specific Blocker of KV3 Channels | 1 mg | 15929 |
B-450 | A Specific Blocker of KV3 Channels | 5 mg | 46631 |
B-450 | A Specific Blocker of KV3 Channels | 10 mg | 64039 |
B-456 | A Neurotrophic Factor | 1 µg | 2567 |
B-456 | A Neurotrophic Factor | 5 x 1 µg | 10251 |
B-456 | A Neurotrophic Factor | 5 µg | 7021 |
B-456 | A Neurotrophic Factor | 5 x 5 µg | 28050 |
B-456 | A Neurotrophic Factor | 10 µg | 12631 |
B-457 | A Neurotrophic Factor | 1 µg | 2567 |
B-457 | A Neurotrophic Factor | 5 x 1 µg | 10251 |
B-457 | A Neurotrophic Factor | 5 µg | 7021 |
B-457 | A Neurotrophic Factor | 5 x 5 µg | 28050 |
B-457 | A Neurotrophic Factor | 10 µg | 12631 |
B-500 | A Selective Antagonist of Endothelin A Receptors | 5 mg | 799 |
B-500 | A Selective Antagonist of Endothelin A Receptors | 10 mg | 1309 |
B-500 | A Selective Antagonist of Endothelin A Receptors | 25 mg | 2941 |
B-500 | A Selective Antagonist of Endothelin A Receptors | 50 mg | 5321 |
C-100 | A Potent Inhibitor of Protein Phosphatase 1 and Protein Phosphatase 2 | 10 µg | 629 |
C-100 | A Potent Inhibitor of Protein Phosphatase 1 and Protein Phosphatase 2 | 25 µg | 1241 |
C-100 | A Potent Inhibitor of Protein Phosphatase 1 and Protein Phosphatase 2 | 50 µg | 2244 |
C-100 | A Potent Inhibitor of Protein Phosphatase 1 and Protein Phosphatase 2 | 0.1 mg | 4131 |
C-105 | A State Dependent Nav Channel Blocker | 5 g | 323 |
C-105 | A State Dependent Nav Channel Blocker | 10 g | 510 |
C-105 | A State Dependent Nav Channel Blocker | 25 g | 884 |
C-110 | A Selective and Potent Opener of KCa2.2 and KCa2.3 Channels and a Blocker of TRPM7 Channel | 5 mg | 884 |
C-110 | A Selective and Potent Opener of KCa2.2 and KCa2.3 Channels and a Blocker of TRPM7 Channel | 10 mg | 1258 |
C-110 | A Selective and Potent Opener of KCa2.2 and KCa2.3 Channels and a Blocker of TRPM7 Channel | 25 mg | 2567 |
C-110 | A Selective and Potent Opener of KCa2.2 and KCa2.3 Channels and a Blocker of TRPM7 Channel | 50 mg | 4437 |
C-115 | A Blocker of KV1.3 and KV1.4 K+ Channels | 5 mg | 1139 |
C-115 | A Blocker of KV1.3 and KV1.4 K+ Channels | 10 mg | 1819 |
C-115 | A Blocker of KV1.3 and KV1.4 K+ Channels | 25 mg | 4301 |
C-115 | A Blocker of KV1.3 and KV1.4 K+ Channels | 50 mg | 7769 |
C-120 | A Selective TRPV1 Antagonist and an Activator of ENaCγ Channels | 5 mg | 459 |
C-120 | A Selective TRPV1 Antagonist and an Activator of ENaCγ Channels | 10 mg | 629 |
C-120 | A Selective TRPV1 Antagonist and an Activator of ENaCγ Channels | 25 mg | 1411 |
C-120 | A Selective TRPV1 Antagonist and an Activator of ENaCγ Channels | 50 mg | 2601 |
C-125 | A Powerful TRPV1 Agonist | 50 mg | 510 |
C-125 | A Powerful TRPV1 Agonist | 100 mg | 697 |
C-125 | A Powerful TRPV1 Agonist | 250 mg | 884 |
C-125 | A Powerful TRPV1 Agonist | 500 mg | 1258 |
C-125 | A Powerful TRPV1 Agonist | 1 g | 2193 |
C-130 | A nAChR Agonist and a Partial Agonist of β2 Subunit | 10 mg | 510 |
C-130 | A nAChR Agonist and a Partial Agonist of β2 Subunit | 25 mg | 1071 |
C-130 | A nAChR Agonist and a Partial Agonist of β2 Subunit | 50 mg | 1836 |
C-130 | A nAChR Agonist and a Partial Agonist of β2 Subunit | 100 mg | 3502 |
C-130 | A nAChR Agonist and a Partial Agonist of β2 Subunit | 250 mg | 7990 |
C-135 | A Blocker of L- and N-Type CaV channels | 5 mg | 629 |
C-135 | A Blocker of L- and N-Type CaV channels | 10 mg | 799 |
C-135 | A Blocker of L- and N-Type CaV channels | 25 mg | 1479 |
C-135 | A Blocker of L- and N-Type CaV channels | 50 mg | 2839 |
C-140 | AMPA/Kainate receptor antagonist | 5 mg | 459 |
C-140 | AMPA/Kainate receptor antagonist | 10 mg | 629 |
C-140 | AMPA/Kainate receptor antagonist | 25 mg | 1258 |
C-140 | AMPA/Kainate receptor antagonist | 50 mg | 1989 |
C-140 | AMPA/Kainate receptor antagonist | 100 mg | 3009 |
C-141 | AMPA/Kainate receptor antagonist | 1 mg | 323 |
C-141 | AMPA/Kainate receptor antagonist | 5 mg | 510 |
C-141 | AMPA/Kainate receptor antagonist | 10 mg | 884 |
C-141 | AMPA/Kainate receptor antagonist | 25 mg | 1836 |
C-141 | AMPA/Kainate receptor antagonist | 50 mg | 3502 |
C-141 | AMPA/Kainate receptor antagonist | 100 mg | 6681 |
C-150 | A Blocker of Presynaptic CaV (N-type and P/Q type) Channels | 30 µg | 1989 |
C-150 | A Blocker of Presynaptic CaV (N-type and P/Q type) Channels | 0.1 mg | 2159 |
C-150 | A Blocker of Presynaptic CaV (N-type and P/Q type) Channels | 0.5 mg | 3944 |
C-150 | A Blocker of Presynaptic CaV (N-type and P/Q type) Channels | 1 mg | 6749 |
C-150 | A Blocker of Presynaptic CaV (N-type and P/Q type) Channels | 2.5 mg | 11849 |
C-150 | A Blocker of Presynaptic CaV (N-type and P/Q type) Channels | 5 mg | 16592 |
C-150 | A Blocker of Presynaptic CaV (N-type and P/Q type) Channels | 10 mg | 23239 |
C-160 | A Potent, State-Dependent Blocker of Neuronal NaV Channels | 5 mg | 697 |
C-160 | A Potent, State-Dependent Blocker of Neuronal NaV Channels | 10 mg | 1071 |
C-160 | A Potent, State-Dependent Blocker of Neuronal NaV Channels | 25 mg | 1836 |
C-160 | A Potent, State-Dependent Blocker of Neuronal NaV Channels | 50 mg | 3315 |
C-165 | A Blocker of nAChRs and an Antagonist of Dopamine Receptors | 5 g | 323 |
C-165 | A Blocker of nAChRs and an Antagonist of Dopamine Receptors | 10 g | 510 |
C-165 | A Blocker of nAChRs and an Antagonist of Dopamine Receptors | 25 g | 884 |
C-165 | A Blocker of nAChRs and an Antagonist of Dopamine Receptors | 50 g | 1632 |
C-165 | A Blocker of nAChRs and an Antagonist of Dopamine Receptors | 100 g | 3128 |
C-170 | A Potent Inhibitor of Protein Phosphatase 1 and Protein Phosphatase 2A | 1 mg | 1258 |
C-170 | A Potent Inhibitor of Protein Phosphatase 1 and Protein Phosphatase 2A | 5 x 1 mg | 5015 |
C-175 | NMDA antagonist | 5 mg | 799 |
C-175 | NMDA antagonist | 10 mg | 1139 |
C-175 | NMDA antagonist | 25 mg | 2601 |
C-175 | NMDA antagonist | 50 mg | 4709 |
C-175 | NMDA antagonist | 100 mg | 8449 |
C-180 | A Blocker of KV1.5 and Kir2.3 Channels and an Antagonist of Adrenoceptors | 50 mg | 459 |
C-180 | A Blocker of KV1.5 and Kir2.3 Channels and an Antagonist of Adrenoceptors | 100 mg | 629 |
C-180 | A Blocker of KV1.5 and Kir2.3 Channels and an Antagonist of Adrenoceptors | 250 mg | 799 |
C-180 | A Blocker of KV1.5 and Kir2.3 Channels and an Antagonist of Adrenoceptors | 500 mg | 969 |
C-180 | A Blocker of KV1.5 and Kir2.3 Channels and an Antagonist of Adrenoceptors | 1 g | 1139 |
C-185 | A Blocker of KV2 Channels and an Inhibitor of 5-HT Uptake | 25 mg | 1819 |
C-185 | A Blocker of KV2 Channels and an Inhibitor of 5-HT Uptake | 50 mg | 3179 |
C-185 | A Blocker of KV2 Channels and an Inhibitor of 5-HT Uptake | 100 mg | 3519 |
C-185 | A Blocker of KV2 Channels and an Inhibitor of 5-HT Uptake | 500 mg | 9231 |
C-185 | A Blocker of KV2 Channels and an Inhibitor of 5-HT Uptake | 1 g | 11781 |
C-190 | A Blocker of CaV1 Channels, a COX-2 Inhibitor and an Opener of KV7 Channels | 100 mg | 629 |
C-190 | A Blocker of CaV1 Channels, a COX-2 Inhibitor and an Opener of KV7 Channels | 250 mg | 1139 |
C-190 | A Blocker of CaV1 Channels, a COX-2 Inhibitor and an Opener of KV7 Channels | 500 mg | 1819 |
C-190 | A Blocker of CaV1 Channels, a COX-2 Inhibitor and an Opener of KV7 Channels | 1 g | 3264 |
C-195 | A Blocker of KV2 Channels and an Inhibitor of 5HT Uptake | 5 mg | 629 |
C-195 | A Blocker of KV2 Channels and an Inhibitor of 5HT Uptake | 10 mg | 799 |
C-195 | A Blocker of KV2 Channels and an Inhibitor of 5HT Uptake | 25 mg | 1139 |
C-195 | A Blocker of KV2 Channels and an Inhibitor of 5HT Uptake | 50 mg | 2108 |
C-195 | A Blocker of KV2 Channels and an Inhibitor of 5HT Uptake | 100 mg | 3859 |
C-200 | human Cardiotrophin-1, Recombinant, <em>E.coli</em> | 5 µg | 1139 |
C-200 | human Cardiotrophin-1, Recombinant, <em>E.coli</em> | 10 µg | 1649 |
C-200 | human Cardiotrophin-1, Recombinant, <em>E.coli</em> | 25 µg | 3281 |
C-205 | A Positive Allosteric Modulator of AMPA Receptors | 10 mg | 459 |
C-205 | A Positive Allosteric Modulator of AMPA Receptors | 25 mg | 969 |
C-205 | A Positive Allosteric Modulator of AMPA Receptors | 50 mg | 1751 |
C-205 | A Positive Allosteric Modulator of AMPA Receptors | 100 mg | 3179 |
C-210 | An Agonist of AMPA Receptors | 5 mg | 799 |
C-210 | An Agonist of AMPA Receptors | 10 mg | 1139 |
C-210 | An Agonist of AMPA Receptors | 25 mg | 2601 |
C-210 | An Agonist of AMPA Receptors | 50 mg | 4709 |
C-210 | An Agonist of AMPA Receptors | 100 mg | 8449 |
C-215 | An AMPA Receptor Positive Allosteric Modulator | 5 mg | 1139 |
C-215 | An AMPA Receptor Positive Allosteric Modulator | 10 mg | 1649 |
C-215 | An AMPA Receptor Positive Allosteric Modulator | 25 mg | 3791 |
C-215 | An AMPA Receptor Positive Allosteric Modulator | 50 mg | 7089 |
C-230 | An Activator of TRPA1 Channels | 5 g | 289 |
C-230 | An Activator of TRPA1 Channels | 10 g | 374 |
C-230 | An Activator of TRPA1 Channels | 25 g | 799 |
C-235 | A Selective Blocker of TRPA1 Channel | 5 mg | 1479 |
C-235 | A Selective Blocker of TRPA1 Channel | 10 mg | 1819 |
C-235 | A Selective Blocker of TRPA1 Channel | 25 mg | 4199 |
C-235 | A Selective Blocker of TRPA1 Channel | 50 mg | 7089 |
C-240 | Human Ciliary Neurotrophic Factor, Recombinant, <em>E. coli</em> | 10 µg | 799 |
C-240 | Human Ciliary Neurotrophic Factor, Recombinant, <em>E. coli</em> | 25 µg | 1581 |
C-240 | Human Ciliary Neurotrophic Factor, Recombinant, <em>E. coli</em> | 50 µg | 2499 |
C-240 | Human Ciliary Neurotrophic Factor, Recombinant, <em>E. coli</em> | 0.1 mg | 4029 |
C-240 | Human Ciliary Neurotrophic Factor, Recombinant, <em>E. coli</em> | 0.25 mg | 8041 |
C-240 | Human Ciliary Neurotrophic Factor, Recombinant, <em>E. coli</em> | 0.5 mg | 12869 |
C-240 | Human Ciliary Neurotrophic Factor, Recombinant, <em>E. coli</em> | 1 mg | 20621 |
C-240 | Human Ciliary Neurotrophic Factor, Recombinant, <em>E. coli</em> | 2.5 mg | 40409 |
C-245 | Rat Ciliary Neurotrophic Factor, Recombinant, <em>E. coli</em> | 10 µg | 799 |
C-245 | Rat Ciliary Neurotrophic Factor, Recombinant, <em>E. coli</em> | 25 µg | 1581 |
C-245 | Rat Ciliary Neurotrophic Factor, Recombinant, <em>E. coli</em> | 50 µg | 2499 |
C-245 | Rat Ciliary Neurotrophic Factor, Recombinant, <em>E. coli</em> | 0.1 mg | 4029 |
C-245 | Rat Ciliary Neurotrophic Factor, Recombinant, <em>E. coli</em> | 0.25 mg | 8041 |
C-245 | Rat Ciliary Neurotrophic Factor, Recombinant, <em>E. coli</em> | 0.5 mg | 12869 |
C-245 | Rat Ciliary Neurotrophic Factor, Recombinant, <em>E. coli</em> | 1 mg | 20621 |
C-245 | Rat Ciliary Neurotrophic Factor, Recombinant, <em>E. coli</em> | 2.5 mg | 40409 |
C-250 | A Potent Inhibitor of Protein Phosphatase 1 and Protein Phosphatase 2A | 1 mg | 1258 |
C-250 | A Potent Inhibitor of Protein Phosphatase 1 and Protein Phosphatase 2A | 5 x 1 mg | 5015 |
C-255 | A TRPA1 and TRPV1 Channel Activator | 5 mg | 1989 |
C-255 | A TRPA1 and TRPV1 Channel Activator | 10 mg | 3179 |
C-255 | A TRPA1 and TRPV1 Channel Activator | 25 mg | 7191 |
C-260 | A Positive Allosteric Modulator of 5-HT3 Receptors | 1 g | 459 |
C-260 | A Positive Allosteric Modulator of 5-HT3 Receptors | 5 g | 2091 |
C-265 | An Antagonist of Angiotensin II Receptor Type-1 and Angiotensin II Receptor Type-2 | 250 mg | 459 |
C-265 | An Antagonist of Angiotensin II Receptor Type-1 and Angiotensin II Receptor Type-2 | 500 mg | 629 |
C-265 | An Antagonist of Angiotensin II Receptor Type-1 and Angiotensin II Receptor Type-2 | 1 g | 969 |
C-265 | An Antagonist of Angiotensin II Receptor Type-1 and Angiotensin II Receptor Type-2 | 5 g | 4199 |
C-265 | An Antagonist of Angiotensin II Receptor Type-1 and Angiotensin II Receptor Type-2 | 10 g | 7429 |
C-266 | An Antagonist of Angiotensin II Receptor Type-1 and Angiotensin II Receptor Type-2 | 50 mg | 629 |
C-266 | An Antagonist of Angiotensin II Receptor Type-1 and Angiotensin II Receptor Type-2 | 100 mg | 799 |
C-266 | An Antagonist of Angiotensin II Receptor Type-1 and Angiotensin II Receptor Type-2 | 500 mg | 1139 |
C-266 | An Antagonist of Angiotensin II Receptor Type-1 and Angiotensin II Receptor Type-2 | 1 g | 1309 |
C-270 | A Selective Blocker of Skeletal Muscle NaV1.4 Channels | 50 µg | 1649 |
C-270 | A Selective Blocker of Skeletal Muscle NaV1.4 Channels | 0.1 mg | 2159 |
C-270 | A Selective Blocker of Skeletal Muscle NaV1.4 Channels | 0.5 mg | 4641 |
C-270 | A Selective Blocker of Skeletal Muscle NaV1.4 Channels | 1 mg | 7429 |
C-270 | A Selective Blocker of Skeletal Muscle NaV1.4 Channels | 5 mg | 26129 |
C-270 | A Selective Blocker of Skeletal Muscle NaV1.4 Channels | 10 mg | 39814 |
C-275 | A Selective Potentiator of GluN2C/GluN2D-Containing NMDA Receptors | 5 mg | 799 |
C-275 | A Selective Potentiator of GluN2C/GluN2D-Containing NMDA Receptors | 10 mg | 1139 |
C-275 | A Selective Potentiator of GluN2C/GluN2D-Containing NMDA Receptors | 25 mg | 2329 |
C-275 | A Selective Potentiator of GluN2C/GluN2D-Containing NMDA Receptors | 50 mg | 3791 |
C-275 | A Selective Potentiator of GluN2C/GluN2D-Containing NMDA Receptors | 100 mg | 6069 |
C-280 | A Potent Blocker of mammalian TTX-sensitive NaV1 Channels | 50 µg | 2380 |
C-280 | A Potent Blocker of mammalian TTX-sensitive NaV1 Channels | 5 x 50 µg | 9503 |
C-280 | A Potent Blocker of mammalian TTX-sensitive NaV1 Channels | 0.1 mg | 3502 |
C-280 | A Potent Blocker of mammalian TTX-sensitive NaV1 Channels | 0.5 mg | 7990 |
C-285 | An Antagonist of NMDA receptors | 10 mg | 629 |
C-285 | An Antagonist of NMDA receptors | 25 mg | 1411 |
C-285 | An Antagonist of NMDA receptors | 50 mg | 2601 |
C-285 | An Antagonist of NMDA receptors | 100 mg | 4709 |
C-286 | An Antagonist of NMDA receptors | 5 mg | 459 |
C-286 | An Antagonist of NMDA receptors | 10 mg | 629 |
C-286 | An Antagonist of NMDA receptors | 25 mg | 1411 |
C-286 | An Antagonist of NMDA receptors | 50 mg | 2601 |
C-290 | A Potent Blocker of Mammalian α3/β2 Neuronal nAChR | 0.1 mg | 1139 |
C-290 | A Potent Blocker of Mammalian α3/β2 Neuronal nAChR | 0.5 mg | 1649 |
C-290 | A Potent Blocker of Mammalian α3/β2 Neuronal nAChR | 1 mg | 2329 |
C-290 | A Potent Blocker of Mammalian α3/β2 Neuronal nAChR | 5 mg | 8143 |
C-290 | A Potent Blocker of Mammalian α3/β2 Neuronal nAChR | 10 mg | 13022 |
C-290-AR | A Potent Antagonist of Mammalian α3/β2 nAChR Conjugated to the Fluorescent Dye ATTO-590 | 10 µg | 4641 |
C-290-AR | A Potent Antagonist of Mammalian α3/β2 nAChR Conjugated to the Fluorescent Dye ATTO-590 | 5 x 10 µg | 13549 |
C-290-AR | A Potent Antagonist of Mammalian α3/β2 nAChR Conjugated to the Fluorescent Dye ATTO-590 | 10 x 10 µg | 18921 |
C-300 | A Blocker of N-Type Ca2+ Channels | 0.1 mg | 1139 |
C-300 | A Blocker of N-Type Ca2+ Channels | 0.25 mg | 1989 |
C-300 | A Blocker of N-Type Ca2+ Channels | 0.5 mg | 2839 |
C-300 | A Blocker of N-Type Ca2+ Channels | 1 mg | 5049 |
C-300 | A Blocker of N-Type Ca2+ Channels | 2.5 mg | 10098 |
C-300 | A Blocker of N-Type Ca2+ Channels | 5 mg | 15929 |
C-300 | A Blocker of N-Type Ca2+ Channels | 10 mg | 22899 |
C-305 | A Potent NMDA Receptor Antagonist | 5 mg | 1139 |
C-305 | A Potent NMDA Receptor Antagonist | 10 mg | 1819 |
C-305 | A Potent NMDA Receptor Antagonist | 25 mg | 4131 |
C-305 | A Potent NMDA Receptor Antagonist | 50 mg | 7429 |
C-310 | An NMDA Receptor Antagonist | 5 mg | 1139 |
C-310 | An NMDA Receptor Antagonist | 10 mg | 1479 |
C-310 | An NMDA Receptor Antagonist | 25 mg | 3349 |
C-310 | An NMDA Receptor Antagonist | 50 mg | 6239 |
C-325 | A Potent and Selective Antagonist of NMDA Receptors | 5 mg | 799 |
C-325 | A Potent and Selective Antagonist of NMDA Receptors | 10 mg | 1309 |
C-325 | A Potent and Selective Antagonist of NMDA Receptors | 25 mg | 2941 |
C-325 | A Potent and Selective Antagonist of NMDA Receptors | 50 mg | 5321 |
C-330 | Topoisomerase Inhibitor | 50 mg | 289 |
C-330 | Topoisomerase Inhibitor | 100 mg | 459 |
C-330 | Topoisomerase Inhibitor | 250 mg | 799 |
C-330 | Topoisomerase Inhibitor | 500 mg | 1139 |
C-335 | Selective, non-competitive AMPA receptor antagonist and NaV1.6 modulator | 5 mg | 1309 |
C-335 | Selective, non-competitive AMPA receptor antagonist and NaV1.6 modulator | 10 mg | 1819 |
C-335 | Selective, non-competitive AMPA receptor antagonist and NaV1.6 modulator | 25 mg | 4199 |
C-335 | Selective, non-competitive AMPA receptor antagonist and NaV1.6 modulator | 50 mg | 7191 |
C-345 | A Potent and Selective Antagonist of Histamine H3 Receptors, An Antagonist of NMDA Receptors | 5 mg | 1139 |
C-345 | A Potent and Selective Antagonist of Histamine H3 Receptors, An Antagonist of NMDA Receptors | 10 mg | 1819 |
C-345 | A Potent and Selective Antagonist of Histamine H3 Receptors, An Antagonist of NMDA Receptors | 25 mg | 3621 |
C-345 | A Potent and Selective Antagonist of Histamine H3 Receptors, An Antagonist of NMDA Receptors | 50 mg | 5049 |
C-355 | An Agonist of AMPA Receptors | 5 mg | 1649 |
C-355 | An Agonist of AMPA Receptors | 10 mg | 2329 |
C-355 | An Agonist of AMPA Receptors | 25 mg | 5219 |
C-355 | An Agonist of AMPA Receptors | 50 mg | 8891 |
C-360 | A Positive Modulator of GABA(A) and Glycine Receptors | 50 mg | 629 |
C-360 | A Positive Modulator of GABA(A) and Glycine Receptors | 100 mg | 799 |
C-360 | A Positive Modulator of GABA(A) and Glycine Receptors | 250 mg | 1139 |
C-360 | A Positive Modulator of GABA(A) and Glycine Receptors | 500 mg | 1649 |
C-360 | A Positive Modulator of GABA(A) and Glycine Receptors | 1 g | 2839 |
C-365 | A Potent and Selective Antagonist of mGluR1 Receptors | 5 mg | 1649 |
C-365 | A Potent and Selective Antagonist of mGluR1 Receptors | 10 mg | 2329 |
C-365 | A Potent and Selective Antagonist of mGluR1 Receptors | 25 mg | 4641 |
C-365 | A Potent and Selective Antagonist of mGluR1 Receptors | 50 mg | 8381 |
C-370 | A Selective, Non-Competitive Antagonist of mGluR1 | 5 mg | 629 |
C-370 | A Selective, Non-Competitive Antagonist of mGluR1 | 10 mg | 799 |
C-370 | A Selective, Non-Competitive Antagonist of mGluR1 | 25 mg | 1819 |
C-370 | A Selective, Non-Competitive Antagonist of mGluR1 | 50 mg | 3349 |
C-370 | A Selective, Non-Competitive Antagonist of mGluR1 | 100 mg | 6001 |
C-385 | An Antagonist of P2X7 Receptors and Inhibitor of Phospholipase D1 | 5 mg | 1139 |
C-385 | An Antagonist of P2X7 Receptors and Inhibitor of Phospholipase D1 | 10 mg | 1819 |
C-385 | An Antagonist of P2X7 Receptors and Inhibitor of Phospholipase D1 | 25 mg | 3689 |
C-385 | An Antagonist of P2X7 Receptors and Inhibitor of Phospholipase D1 | 50 mg | 5899 |
C-390 | A Partial Agonist of GABA(A) Receptors | 5 mg | 799 |
C-390 | A Partial Agonist of GABA(A) Receptors | 10 mg | 1139 |
C-390 | A Partial Agonist of GABA(A) Receptors | 25 mg | 2601 |
C-390 | A Partial Agonist of GABA(A) Receptors | 50 mg | 4369 |
C-400 | A Protein Kinase C Inhibitor | 1 mg | 510 |
C-400 | A Protein Kinase C Inhibitor | 5 x 1 mg | 2023 |
C-400 | A Protein Kinase C Inhibitor | 5 mg | 1632 |
C-500 | A Specific Blocker of L-type CaV Channels | 70 µg | 3706 |
C-500 | A Specific Blocker of L-type CaV Channels | 5 x 70 µg | 14807 |
C-550 | An Anticancer compound and a Protein Synthesis and Transport Inhibitor | 1 mg | 1836 |
C-550 | An Anticancer compound and a Protein Synthesis and Transport Inhibitor | 5 x 1 mg | 7327 |
C-670 | A Specific Blocker of CaV2.2 Channel | 50 µg | 1139 |
C-670 | A Specific Blocker of CaV2.2 Channel | 0.1 mg | 1649 |
C-670 | A Specific Blocker of CaV2.2 Channel | 0.5 mg | 3349 |
C-670 | A Specific Blocker of CaV2.2 Channel | 1 mg | 5389 |
C-670 | A Specific Blocker of CaV2.2 Channel | 5 mg | 15929 |
C-670 | A Specific Blocker of CaV2.2 Channel | 10 mg | 24191 |
C-750 | A Potent Inhibitor of Intracellular Ca2+-ATPase Pump | 5 mg | 799 |
C-750 | A Potent Inhibitor of Intracellular Ca2+-ATPase Pump | 10 mg | 1309 |
C-750 | A Potent Inhibitor of Intracellular Ca2+-ATPase Pump | 25 mg | 2941 |
C-750 | A Potent Inhibitor of Intracellular Ca2+-ATPase Pump | 50 mg | 5389 |
C-850 | An Inhibitor of Protein Synthesis | 100 mg | 510 |
C-850 | An Inhibitor of Protein Synthesis | 5 x 100 mg | 1836 |
C-850 | An Inhibitor of Protein Synthesis | 10 x 100 mg | 2380 |
C-850 | An Inhibitor of Protein Synthesis | 1 g | 1037 |
C-900 | An Immunosuppressant and an Inhibitor of Protein Phosphatase 2B | 25 mg | 697 |
C-900 | An Immunosuppressant and an Inhibitor of Protein Phosphatase 2B | 5 x 25 mg | 2771 |
C-900 | An Immunosuppressant and an Inhibitor of Protein Phosphatase 2B | 100 mg | 1258 |
CMG-004 | A Novel Antagonist of GABA(A) α5 Receptors | 5 mg | 2839 |
CMG-004 | A Novel Antagonist of GABA(A) α5 Receptors | 10 mg | 5049 |
CMG-004 | A Novel Antagonist of GABA(A) α5 Receptors | 25 mg | 10149 |
CMG-004 | A Novel Antagonist of GABA(A) α5 Receptors | 50 mg | 16439 |
CMN-002 | A Modulator of NaV1.1 Channel | 5 mg | 1139 |
CMN-002 | A Modulator of NaV1.1 Channel | 10 mg | 1819 |
CMN-002 | A Modulator of NaV1.1 Channel | 25 mg | 3621 |
CMN-002 | A Modulator of NaV1.1 Channel | 50 mg | 5831 |
CMN-003 | A Potent and Selective Blocker of NaV1.7 Channels | 5 mg | 2839 |
CMN-003 | A Potent and Selective Blocker of NaV1.7 Channels | 10 mg | 4539 |
CMN-003 | A Potent and Selective Blocker of NaV1.7 Channels | 25 mg | 9078 |
CMN-003 | A Potent and Selective Blocker of NaV1.7 Channels | 50 mg | 15759 |
D-100 | A Potent and Highly Selective Blocker of KV11.1 (hERG) Channels | 5 mg | 884 |
D-100 | A Potent and Highly Selective Blocker of KV11.1 (hERG) Channels | 10 mg | 1258 |
D-100 | A Potent and Highly Selective Blocker of KV11.1 (hERG) Channels | 25 mg | 1632 |
D-100 | A Potent and Highly Selective Blocker of KV11.1 (hERG) Channels | 50 mg | 2754 |
D-110 | Antagonist or Partial Agonist of nAChR | 5 mg | 1258 |
D-110 | Antagonist or Partial Agonist of nAChR | 10 mg | 1632 |
D-110 | Antagonist or Partial Agonist of nAChR | 50 mg | 6511 |
D-125 | An Agonist of nAChR | 1 g | 323 |
D-125 | An Agonist of nAChR | 5 g | 1445 |
D-125 | An Agonist of nAChR | 10 g | 2567 |
D-130 | AMPA/Kainate Receptor Antagonist | 10 mg | 510 |
D-130 | AMPA/Kainate Receptor Antagonist | 25 mg | 1156 |
D-130 | AMPA/Kainate Receptor Antagonist | 50 mg | 2006 |
D-130 | AMPA/Kainate Receptor Antagonist | 100 mg | 3349 |
D-130 | AMPA/Kainate Receptor Antagonist | 250 mg | 6239 |
D-131 | AMPA/Kainate receptor antagonist | 10 mg | 289 |
D-131 | AMPA/Kainate receptor antagonist | 25 mg | 459 |
D-131 | AMPA/Kainate receptor antagonist | 50 mg | 731 |
D-131 | AMPA/Kainate receptor antagonist | 100 mg | 1173 |
D-131 | AMPA/Kainate receptor antagonist | 250 mg | 2329 |
D-135 | A Potent and Selective Blocker of L-type CaV Channels | 1 g | 323 |
D-135 | A Potent and Selective Blocker of L-type CaV Channels | 5 g | 1258 |
D-135 | A Potent and Selective Blocker of L-type CaV Channels | 10 g | 2193 |
D-140 | A Competitive NMDA Receptor Antagonist | 5 mg | 374 |
D-140 | A Competitive NMDA Receptor Antagonist | 10 mg | 629 |
D-140 | A Competitive NMDA Receptor Antagonist | 25 mg | 1411 |
D-140 | A Competitive NMDA Receptor Antagonist | 50 mg | 2159 |
D-140 | A Competitive NMDA Receptor Antagonist | 100 mg | 3281 |
D-140 | A Competitive NMDA Receptor Antagonist | 250 mg | 12342 |
D-140 | A Competitive NMDA Receptor Antagonist | 500 mg | 19499 |
D-145 | A Competitive NMDA Receptor Antagonist | 1 mg | 442 |
D-145 | A Competitive NMDA Receptor Antagonist | 5 mg | 697 |
D-145 | A Competitive NMDA Receptor Antagonist | 10 mg | 952 |
D-145 | A Competitive NMDA Receptor Antagonist | 25 mg | 2227 |
D-145 | A Competitive NMDA Receptor Antagonist | 50 mg | 3791 |
D-145 | A Competitive NMDA Receptor Antagonist | 100 mg | 6171 |
D-145 | A Competitive NMDA Receptor Antagonist | 250 mg | 12342 |
D-145 | A Competitive NMDA Receptor Antagonist | 500 mg | 19499 |
D-150 | A KV7 Channel Opener | 5 mg | 629 |
D-150 | A KV7 Channel Opener | 10 mg | 1139 |
D-150 | A KV7 Channel Opener | 25 mg | 1649 |
D-150 | A KV7 Channel Opener | 50 mg | 3281 |
D-165 | A Blocker of TRPA1 Channel and Selective blocker of Na+/H+ Antiport | 5 mg | 459 |
D-165 | A Blocker of TRPA1 Channel and Selective blocker of Na+/H+ Antiport | 10 mg | 799 |
D-165 | A Blocker of TRPA1 Channel and Selective blocker of Na+/H+ Antiport | 25 mg | 1819 |
D-165 | A Blocker of TRPA1 Channel and Selective blocker of Na+/H+ Antiport | 50 mg | 3281 |
D-165 | A Blocker of TRPA1 Channel and Selective blocker of Na+/H+ Antiport | 100 mg | 5899 |
D-170 | A Blocker of KV4.3 and an Inhibitor of 5-HT and Norepinephrine (NE) Re-Uptake | 25 mg | 459 |
D-170 | A Blocker of KV4.3 and an Inhibitor of 5-HT and Norepinephrine (NE) Re-Uptake | 50 mg | 799 |
D-170 | A Blocker of KV4.3 and an Inhibitor of 5-HT and Norepinephrine (NE) Re-Uptake | 100 mg | 1479 |
D-170 | A Blocker of KV4.3 and an Inhibitor of 5-HT and Norepinephrine (NE) Re-Uptake | 250 mg | 3009 |
D-175 | A Blocker of KV4.3 and KV1.5 Channels and an Inhibitor of 5-HT Re-Uptake | 10 mg | 629 |
D-175 | A Blocker of KV4.3 and KV1.5 Channels and an Inhibitor of 5-HT Re-Uptake | 25 mg | 799 |
D-175 | A Blocker of KV4.3 and KV1.5 Channels and an Inhibitor of 5-HT Re-Uptake | 50 mg | 1411 |
D-175 | A Blocker of KV4.3 and KV1.5 Channels and an Inhibitor of 5-HT Re-Uptake | 100 mg | 2499 |
D-180 | An Opener of KV7 Channels | 1 g | 459 |
D-180 | An Opener of KV7 Channels | 5 g | 629 |
D-180 | An Opener of KV7 Channels | 10 g | 1139 |
D-180 | An Opener of KV7 Channels | 25 g | 2601 |
D-181 | An Opener of KV7 Channels | 5 g | 289 |
D-181 | An Opener of KV7 Channels | 25 g | 459 |
D-181 | An Opener of KV7 Channels | 50 g | 629 |
D-190 | An Antagonist of NMDA Receptors | 10 mg | 629 |
D-190 | An Antagonist of NMDA Receptors | 25 mg | 1411 |
D-190 | An Antagonist of NMDA Receptors | 50 mg | 2601 |
D-190 | An Antagonist of NMDA Receptors | 100 mg | 4709 |
D-191 | An Antagonist of NMDA Receptors | 10 mg | 1139 |
D-191 | An Antagonist of NMDA Receptors | 25 mg | 2601 |
D-191 | An Antagonist of NMDA Receptors | 50 mg | 4641 |
D-191 | An Antagonist of NMDA Receptors | 100 mg | 8381 |
D-191 | An Antagonist of NMDA Receptors | 250 mg | 14229 |
D-195 | A Potent Activator of TRPM8 Channels | 5 mg | 2329 |
D-195 | A Potent Activator of TRPM8 Channels | 10 mg | 3621 |
D-195 | A Potent Activator of TRPM8 Channels | 25 mg | 7191 |
D-195 | A Potent Activator of TRPM8 Channels | 50 mg | 11509 |
D-200 | An Antagonist of NMDA Receptors | 5 mg | 459 |
D-200 | An Antagonist of NMDA Receptors | 10 mg | 799 |
D-200 | An Antagonist of NMDA Receptors | 25 mg | 1819 |
D-200 | An Antagonist of NMDA Receptors | 50 mg | 3281 |
D-210 | A Potent Noncompetitive Antagonist of GluN2D/C-Containing NMDA Receptors | 5 mg | 1139 |
D-210 | A Potent Noncompetitive Antagonist of GluN2D/C-Containing NMDA Receptors | 10 mg | 1649 |
D-210 | A Potent Noncompetitive Antagonist of GluN2D/C-Containing NMDA Receptors | 25 mg | 3689 |
D-210 | A Potent Noncompetitive Antagonist of GluN2D/C-Containing NMDA Receptors | 50 mg | 6681 |
D-215 | An Activator of GABA(A) Receptors | 50 mg | 629 |
D-215 | An Activator of GABA(A) Receptors | 100 mg | 799 |
D-215 | An Activator of GABA(A) Receptors | 250 mg | 1581 |
D-215 | An Activator of GABA(A) Receptors | 1 g | 5049 |
D-255 | A Selective Antagonist of mGluR1 Receptors | 5 mg | 1649 |
D-255 | A Selective Antagonist of mGluR1 Receptors | 10 mg | 2329 |
D-255 | A Selective Antagonist of mGluR1 Receptors | 25 mg | 4641 |
D-255 | A Selective Antagonist of mGluR1 Receptors | 50 mg | 8381 |
D-265 | A Selective Antagonist of Endothelin A Receptors | 5 mg | 2329 |
D-265 | A Selective Antagonist of Endothelin A Receptors | 10 mg | 3349 |
D-265 | A Selective Antagonist of Endothelin A Receptors | 25 mg | 5899 |
D-265 | A Selective Antagonist of Endothelin A Receptors | 50 mg | 9129 |
D-275 | An Antagonist of mGluR1 Receptors | 50 mg | 459 |
D-275 | An Antagonist of mGluR1 Receptors | 100 mg | 629 |
D-275 | An Antagonist of mGluR1 Receptors | 250 mg | 1258 |
D-275 | An Antagonist of mGluR1 Receptors | 500 mg | 2159 |
D-350 | A Potent Blocker of KV1.1, KV1.2 and KV1.6 Channels | 50 µg | 2839 |
D-350 | A Potent Blocker of KV1.1, KV1.2 and KV1.6 Channels | 0.14 mg | 5933 |
D-350 | A Potent Blocker of KV1.1, KV1.2 and KV1.6 Channels | 5 x 0.14 mg | 23715 |
D-360 | A Potent Blocker of KV1.1 and KV1.2 Channels | 35 µg | 5933 |
D-360 | A Potent Blocker of KV1.1 and KV1.2 Channels | 5 x 35 µg | 23715 |
D-370 | A Potent and Specific Blocker of KV1.1 Channels | 70 µg | 5933 |
D-370 | A Potent and Specific Blocker of KV1.1 Channels | 5 x 70 µg | 23715 |
D-380 | A Potent and Specific Blocker of KV1.1 Channels | 70 µg | 2839 |
D-380 | A Potent and Specific Blocker of KV1.1 Channels | 0.5 mg | 12699 |
D-380 | A Potent and Specific Blocker of KV1.1 Channels | 1 mg | 16541 |
D-380 | A Potent and Specific Blocker of KV1.1 Channels | 5 mg | 59041 |
D-390 | A Potent Blocker of KV1.1 and KV1.2 Channels | 0.14 mg | 5933 |
D-390 | A Potent Blocker of KV1.1 and KV1.2 Channels | 5 x 0.14 mg | 23715 |
D-400 | A Potent Blocker of KV1.1 Channels | 10 µg | 2329 |
D-400 | A Potent Blocker of KV1.1 Channels | 70 µg | 5933 |
D-800 | A Anticancer Compound and Apoptosis Inducer | 5 mg | 1445 |
D-800 | A Anticancer Compound and Apoptosis Inducer | 5 x 5 mg | 5763 |
D-800 | A Anticancer Compound and Apoptosis Inducer | 25 mg | 5576 |
E-100 | Human Epidermal Growth Factor, Recombinant, <em>E. coli</em> | 0.1 mg | 629 |
E-100 | Human Epidermal Growth Factor, Recombinant, <em>E. coli</em> | 0.2 mg | 799 |
E-100 | Human Epidermal Growth Factor, Recombinant, <em>E. coli</em> | 0.5 mg | 1309 |
E-100 | Human Epidermal Growth Factor, Recombinant, <em>E. coli</em> | 1 mg | 2329 |
E-100 | Human Epidermal Growth Factor, Recombinant, <em>E. coli</em> | 2.5 mg | 5219 |
E-100 | Human Epidermal Growth Factor, Recombinant, <em>E. coli</em> | 5 mg | 9401 |
E-110 | A Blocker of AMPA/Kainate receptors, P2X Receptors and a Potent Inhibitor of L-Glutamate Uptake | 1 g | 323 |
E-110 | A Blocker of AMPA/Kainate receptors, P2X Receptors and a Potent Inhibitor of L-Glutamate Uptake | 10 g | 510 |
E-110 | A Blocker of AMPA/Kainate receptors, P2X Receptors and a Potent Inhibitor of L-Glutamate Uptake | 50 g | 2023 |
E-140 | A Selective Activator of TRPA1 Channel | 50 mg | 459 |
E-140 | A Selective Activator of TRPA1 Channel | 100 mg | 629 |
E-140 | A Selective Activator of TRPA1 Channel | 250 mg | 799 |
E-140 | A Selective Activator of TRPA1 Channel | 1 g | 1649 |
E-145 | An Antagonist of Angiotensin II Receptor Type I | 50 mg | 799 |
E-145 | An Antagonist of Angiotensin II Receptor Type I | 100 mg | 1139 |
E-145 | An Antagonist of Angiotensin II Receptor Type I | 250 mg | 1989 |
E-145 | An Antagonist of Angiotensin II Receptor Type I | 1 g | 6239 |
E-150 | A Potent Activator of KCa3.1 and KCa2 Channels | 10 mg | 289 |
E-150 | A Potent Activator of KCa3.1 and KCa2 Channels | 25 mg | 629 |
E-150 | A Potent Activator of KCa3.1 and KCa2 Channels | 50 mg | 1139 |
E-150 | A Potent Activator of KCa3.1 and KCa2 Channels | 100 mg | 1989 |
E-150 | A Potent Activator of KCa3.1 and KCa2 Channels | 250 mg | 4029 |
E-155 | An Antagonist of NMDA Receptors and Blocker of N- and P-Type CaV Channels | 5 mg | 629 |
E-155 | An Antagonist of NMDA Receptors and Blocker of N- and P-Type CaV Channels | 10 mg | 799 |
E-155 | An Antagonist of NMDA Receptors and Blocker of N- and P-Type CaV Channels | 25 mg | 1819 |
E-155 | An Antagonist of NMDA Receptors and Blocker of N- and P-Type CaV Channels | 50 mg | 3281 |
E-160 | An Antagonist of Angiotensin II Receptor Type-1 | 5 mg | 1139 |
E-160 | An Antagonist of Angiotensin II Receptor Type-1 | 10 mg | 1989 |
E-160 | An Antagonist of Angiotensin II Receptor Type-1 | 25 mg | 4471 |
E-160 | An Antagonist of Angiotensin II Receptor Type-1 | 50 mg | 8041 |
E-165 | A Potent and Selective Antagonist of Rat mGluR1 Receptors | 5 mg | 1649 |
E-165 | A Potent and Selective Antagonist of Rat mGluR1 Receptors | 10 mg | 2329 |
E-165 | A Potent and Selective Antagonist of Rat mGluR1 Receptors | 25 mg | 4641 |
E-165 | A Potent and Selective Antagonist of Rat mGluR1 Receptors | 50 mg | 8381 |
E-175 | An Antagonist of GABA(A) Receptors | 50 mg | 1139 |
E-175 | An Antagonist of GABA(A) Receptors | 100 mg | 1649 |
E-175 | An Antagonist of GABA(A) Receptors | 250 mg | 2839 |
E-175 | An Antagonist of GABA(A) Receptors | 500 mg | 4539 |
E-180 | An Inhibitor of Protein Phosphatase 1 and Protein Phosphatase 2A | 5 mg | 1258 |
E-180 | An Inhibitor of Protein Phosphatase 1 and Protein Phosphatase 2A | 5 x 5 mg | 5015 |
E-200 | A Potentiator of GABA(A) Transmission and 5-HT3A Channel Antagonist | 10 mg | 935 |
E-200 | A Potentiator of GABA(A) Transmission and 5-HT3A Channel Antagonist | 50 mg | 2159 |
E-200 | A Potentiator of GABA(A) Transmission and 5-HT3A Channel Antagonist | 100 mg | 4029 |
E-500 | A Blocker of KV11.1 (hERG) K+ Channels | 0.5 mg | 697 |
E-500 | A Blocker of KV11.1 (hERG) K+ Channels | 1 mg | 884 |
E-500 | A Blocker of KV11.1 (hERG) K+ Channels | 5 mg | 1632 |
E-500 | A Blocker of KV11.1 (hERG) K+ Channels | 10 mg | 2193 |
E-500 | A Blocker of KV11.1 (hERG) K+ Channels | 25 mg | 3706 |
E-500 | A Blocker of KV11.1 (hERG) K+ Channels | 50 mg | 6494 |
EK-100 | A screening package of Intracellular Ca2+ Modulators economically priced | 22 vials | 8925 |
EK-101 | A screening package of KCa Channel Blockes economically priced | 16 vials | 9860 |
EK-103 | A screening package of L-Type CaV Channel Blockers economically priced | 24 vials | 11832 |
EK-105 | A screening package of TTX-Sensitive NaV Channel Blockers economically priced | 35 vials | 27234 |
EK-106 | A screening package of TTX-Resistant NaV Channel Blockers economically priced | 23 vials | 16303 |
EK-107 | A screening package of <em>Shaker</em> (KV1) Channel Blockers economically priced | 30 vials | 32419 |
EK-108 | A screening package of <em>Shaker</em> (KV)-Related Channel Blockers economically priced | 21 vials | 18989 |
EK-109 | A screening package of hERG Related Channel Modulators economically priced | 12 vials | 9758 |
EK-110 | A screening package of CaV2 Channel Blockers economically priced | 21 vials | 19788 |
EK-111 | A screening package of T-Type CaV Channel Blockers economically priced | 19 vials | 11509 |
EK-112 | A screening package of Kir Channel Blockers economically priced | 9 vials | 6868 |
EK-113 | A screening package of ASIC Channel Modulators economically priced | 11 vials | 10472 |
EK-114 | A screening package of TRPV1 Channel Modulators economically priced | 14 vials | 6528 |
EK-115 | A Screening Package of TRPV1 Channel Activators Economically Priced | 9 vials | 6443 |
EK-117 | A Screening Package of TRPV1 Channel Blockers Economically Priced | 8 vials | 5236 |
EK-120 | A Screening Package of TRPA1 Channel Modulators Economically Priced | 14 vials | 6715 |
EK-121 | A Screening Package of TRPA1 Channel Blockers Economically Priced | 8 vials | 5321 |
EK-122 | A Screening Package of KCa2 Channel Modulators Economically Priced | 9 vials | 5253 |
EK-123 | A Screening Package of TRPA1 Channel Activators Economically Priced | 8 vials | 4420 |
EK-130 | A Screening Package of KV4 Channel Blockers Economically Priced | 14 vials | 11832 |
EK-131 | A Screening Package of KCNQ (KV7) Channel Modulators Economically Priced | 12 vials | 6664 |
EK-132 | A Screening Package of KCa1.1 Channel Modulators Economically Priced | 13 vials | 9265 |
EK-133 | A Screening Package of KCNN4 Channel Modulators Economically Priced | 8 vials | 5134 |
EK-150 | A Screening Package of TRPM8 Channel Activators Economically Priced | 5 vials | 3400 |
EK-151 | A Screening Package of TRPM8 Channel Blockers Economically Priced | 6 vials | 4794 |
EK-152 | A Screening Package of TRPM8 Channel Modulators Economically Priced | 11 vials | 7021 |
EK-201 | A screening package of KCa Channel Openers economically priced | 10 vials | 5236 |
EK-202 | A screening package of nAChR Modulators economically priced | 16 vials | 9282 |
EK-203 | A screening package of NaV Channel Activators economically priced | 12 vials | 9418 |
EK-204 | A screening package of nAChR Activators economically priced | 9 vials | 4420 |
EK-205 | A screening package of nAChR Blockers economically priced | 19 vials | 12393 |
EK-206 | A screening package of Muscarinic Receptor Antagonists economically priced | 6 vials | 4607 |
EK-207 | A screening package of Muscle Specific nAChR antagonists economically priced | 10 vials | 6681 |
EK-208 | A Screening Package of 5-HT3 Receptor Blockers Economically Priced | 24 vials | 10302 |
EK-209 | A Screening Package of 5-HT3 Receptor Modulators Economically Priced | 31 vials | 13447 |
EK-210 | A Screening Package of AMPA Receptor Blockers Economically Priced | 15 vials | 6222 |
EK-211 | A Screening Package of AMPA Receptor Modulators Economically Priced | 22 vials | 9996 |
EK-212 | A Screening Package of AMPA Receptor Activators Economically Priced | 8 vials | 4131 |
EK-220 | A Screening Package of KV2 Channel Blockers Economically Priced | 6 vials | 7191 |
EK-225 | A Screening Package of KCNQ (KV7) Channel Activators Economically Priced | 9 vials | 5270 |
EK-250 | A Screening Package of mGluR1 Antagonists Economically Priced | 13 vials | 9282 |
EK-255 | A Screening Package of Endothelin Receptor Agonists Economically Priced | 4 vials | 4386 |
EK-256 | A Screening Package of Endothelin Receptor Antagonists Economically Priced | 19 vials | 13804 |
EK-257 | A Screening Package of Endothelin Receptor Pharmacology Economically Priced | 19 vials | 14314 |
EK-345 | A Screening Package of Cardiac Channel Blockers Economically Priced | 20 vials | 16269 |
EK-350 | A Screening Package of NMDA Receptor Blockers Economically Priced | 17 vials | 5848 |
EK-355 | A Screening Package of Classical Ion Channel Blockers for Pain Research Economically Priced | 26 vials | 16218 |
EK-360 | A Screening Package of GABA(A) Receptor Modulators Economically Priced | 15 vials | 7395 |
EK-365 | A Screening Package of SERCA Pump Inhibitors Economically Priced | 6 vials | 2873 |
EK-370 | A Screening Package of Angiotensin II Receptor Antagonists Economically Priced | 8 vials | 3179 |
EK-375 | A Screening Package of NaV Channel Blockers for Pain Research Economically Priced | 11 vials | 9350 |
EK-380 | A Screening Package of KV Channel Blockers for Pain Research Economically Priced | 9 vials | 11798 |
EK-385 | A Screening Package of CaV Channel Blockers for Pain Research Economically Priced | 13 vials | 13566 |
EK-390 | A Screening Package of K+ Channel Blockers for Pain Research Economically Priced | 14 vials | 15232 |
EK-395 | A Screening Package of Ion Channel Activators for Pain Research Economically Priced | 9 vials | 6222 |
EK-405 | A Screening Package of Angiotensin II Receptor Pharmacology Economically Priced | 10 vials | 4879 |
EK-410 | A Screening Package of P2X7 Receptor Antagonists Economically Priced | 13 vials | 7565 |
EK-500 | A screening package of Neurotrophic Factors economically priced | 42 vials | 11798 |
ESB-001 | All You Need for NaV1.7 Channel Research | 7 vials | 13532 |
ESP-001 | All You Need for NaV1.7 Channel Research | 11 vials | 19465 |
ESD-001 | All You Need for NaV1.7 Channel Research | 14 vials | 25109 |
ESB-002 | All You Need for NaV1.2 Channel Research | 6 vials | 10081 |
ESP-002 | All You Need for NaV1.2 Channel Research | 10 vials | 16864 |
ESD-002 | All You Need for NaV1.2 Channel Research | 13 vials | 21998 |
ESB-003 | All You Need for NaV1.8 Channel Research | 5 vials | 9537 |
ESP-003 | All You Need for NaV1.8 Channel Research | 8 vials | 15589 |
ESD-003 | All You Need for NaV1.8 Channel Research | 11 vials | 20791 |
ESB-100 | All You Need for CaV1.2 (CACNA1C) Channel Research | 8 vials | 11186 |
ESP-100 | All You Need for CaV1.2 (CACNA1C) Channel Research | 14 vials | 20995 |
ESD-100 | All You Need for CaV1.2 (CACNA1C) Channel Research | 16 vials | 25483 |
ESB-101 | All You Need for T-Type CaV Channel Research | 8 vials | 14450 |
ESP-101 | All You Need for T-Type CaV Channel Research | 10 vials | 16269 |
ESD-101 | All You Need for T-Type CaV Channel Research | 13 vials | 23783 |
ESB-200 | All You Need for ASIC1 Channel Research | 6 vials | 10880 |
ESP-200 | All You Need for ASIC1 Channel Research | 9 vials | 17884 |
ESB-201 | All You Need for ASIC3 Channel Research | 8 vials | 11832 |
ESP-201 | All You Need for ASIC3 Channel Research | 13 vials | 17578 |
ESB-300 | All You Need for TRPV1 Channel Research | 7 vials | 9877 |
ESP-300 | All You Need for TRPV1 Channel Research | 9 vials | 15215 |
ESD-300 | All You Need for TRPV1 Channel Research | 11 vials | 19703 |
ESB-301 | All You Need for TRPM8 Channel Research | 6 vials | 7888 |
ESB-302 | All You Need for TRPA1 Channel Research | 6 vials | 8398 |
ESB-400 | All You Need for KCNN4 (KCa3.1) Channel Research | 7 vials | 8908 |
ESP-400 | All You Need for KCNN4 (KCa3.1) Channel Research | 9 vials | 14382 |
ESD-400 | All You Need for KCNN4 (KCa3.1) Channel Research | 10 vials | 20298 |
ESB-500 | All You Need for KV1.2 (KCNA2) Channel Research | 8 vials | 16354 |
ESP-500 | All You Need for KV1.2 (KCNA2) Channel Research | 10 vials | 17646 |
ESD-500 | All You Need for KV1.2 (KCNA2) Channel Research | 11 vials | 22083 |
ESB-501 | All You Need for KV1.3 (KCNA3) Channel Research | 6 vials | 10523 |
ESP-501 | All You Need for KV1.3 (KCNA3) Channel Research | 10 vials | 17952 |
ESD-501 | All You Need for KV1.3 (KCNA3) Channel Research | 11 vials | 20434 |
ESB-502 | All You Need for KV4 Channel Research | 8 vials | 14110 |
ESP-502 | All You Need for KV4 Channel Research | 11 vials | 18598 |
ESD-502 | All You Need for KV4 Channel Research | 14 vials | 26843 |
ESB-503 | All You Need for KCNQ (KV7) Channels Research | 15 vials | 26180 |
ESB-600 | All You Need for BDNF Research | 9 vials | 15776 |
ESP-600 | All You Need for BDNF Research | 12 vials | 22593 |
ESD-600 | All You Need for BDNF Research | 16 vials | 31552 |
ESB-601 | All You Need for proBDNF Research | 6 vials | 10489 |
ESP-601 | All You Need for proBDNF Research | 8 vials | 14535 |
ESD-601 | All You Need for proBDNF Research | 13 vials | 27200 |
ESB-602 | All You Need for proBDNF Research | 6 vials | 12274 |
ESP-602 | All You Need for proBDNF Research | 8 vials | 16320 |
ESD-602 | All You Need for proBDNF Research | 12 vials | 25279 |
ESB-650 | All You Need for NGF Research | 8 vials | 14501 |
ESP-650 | All You Need for NGF Research | 10 vials | 19210 |
ESD-650 | All You Need for NGF Research | 14 vials | 28169 |
ESB-651 | All You Need for NGF Research | 8 vials | 15657 |
ESP-651 | All You Need for NGF Research | 10 vials | 20366 |
ESD-651 | All You Need for NGF Research | 14 vials | 29325 |
ESB-652 | All You Need for proNGF Research | 6 vials | 11084 |
ESP-652 | All You Need for proNGF Research | 8 vials | 15130 |
ESD-652 | All You Need for proNGF Research | 11 vials | 23919 |
ESB-653 | All You Need for proNGF Research | 6 vials | 10914 |
ESP-653 | All You Need for proNGF Research | 8 vials | 14960 |
ESD-653 | All You Need for proNGF Research | 11 vials | 23749 |
ESB-700 | All You Need for AMPA Receptor 1 Research | 8 vials | 10234 |
ESP-700 | All You Need for AMPA Receptor 1 Research | 12 vials | 16728 |
ESD-700 | All You Need for AMPA Receptor 1 Research | 16 vials | 23171 |
ESB-705 | All You Need for AMPA Receptor 2 Research | 7 vials | 10013 |
ESP-705 | All You Need for AMPA Receptor 2 Research | 12 vials | 17680 |
ESD-705 | All You Need for AMPA Receptor 2 Research | 16 vials | 24225 |
ESB-750 | All You Need for NMDA Receptor 2B Research | 5 vials | 8772 |
ESP-750 | All You Need for NMDA Receptor 2B Research | 7 vials | 9588 |
ESD-750 | All You Need for NMDA Receptor 2B Research | 11 vials | 16099 |
ESB-800 | All You Need for GABA(A) α1 Receptor Research | 4 vials | 6936 |
ESP-800 | All You Need for GABA(A) α1 Receptor Research | 7 vials | 10557 |
ESD-800 | All You Need for GABA(A) α1 Receptor Research | 10 vials | 16201 |
ESB-900 | All You Need for nAChR Research | 6 vials | 10098 |
ESP-900 | All You Need for nAChR Research | 8 vials | 12070 |
ESD-900 | All You Need for nAChR Research | 9 vials | 13226 |
ESB-940 | All You Need for Endothelin Receptors Research | 12 vials | 24106 |
ESB-950 | All You Need for Angiotensin II Receptor Research | 8 vials | 11679 |
ESP-950 | All You Need for Angiotensin II Receptor Research | 12 vials | 14858 |
ESD-950 | All You Need for Angiotensin II Receptor Research | 16 vials | 23817 |
F-105 | A Potent and Selective Blocker of L-type CaV Channels | 5 mg | 510 |
F-105 | A Potent and Selective Blocker of L-type CaV Channels | 10 mg | 697 |
F-105 | A Potent and Selective Blocker of L-type CaV Channels | 25 mg | 1258 |
F-105 | A Potent and Selective Blocker of L-type CaV Channels | 50 mg | 2193 |
F-110 | A Potent Blocker of L-type and T-type CaV Channels | 1 g | 510 |
F-110 | A Potent Blocker of L-type and T-type CaV Channels | 5 g | 1632 |
F-110 | A Potent Blocker of L-type and T-type CaV Channels | 10 g | 2567 |
F-120 | A Blocker of P-Type CaV Channels | 1 mg | 2567 |
F-120 | A Blocker of P-Type CaV Channels | 5 x 1 mg | 10251 |
F-130 | A Blocker of P-Type CaV Channels | 1 mg | 3502 |
F-130 | A Blocker of P-Type CaV Channels | 5 x 1 mg | 13991 |
F-140 | A Blocker of Voltage-Gated L-Type Ca2+ Channels | 10 mg | 510 |
F-140 | A Blocker of Voltage-Gated L-Type Ca2+ Channels | 25 mg | 884 |
F-140 | A Blocker of Voltage-Gated L-Type Ca2+ Channels | 50 mg | 1258 |
F-140 | A Blocker of Voltage-Gated L-Type Ca2+ Channels | 100 mg | 1836 |
F-145 | An Antagonist of GABA(A) Receptors | 25 mg | 459 |
F-145 | An Antagonist of GABA(A) Receptors | 50 mg | 629 |
F-145 | An Antagonist of GABA(A) Receptors | 100 mg | 1479 |
F-145 | An Antagonist of GABA(A) Receptors | 250 mg | 3349 |
F-150 | A Potent and Selective Modulator of KV7 Channels | 5 mg | 510 |
F-150 | A Potent and Selective Modulator of KV7 Channels | 10 mg | 884 |
F-150 | A Potent and Selective Modulator of KV7 Channels | 25 mg | 1632 |
F-150 | A Potent and Selective Modulator of KV7 Channels | 50 mg | 2941 |
F-155 | A Blocker of KV4.3 Channels and a Competitive Inhibitor of 5-HT Re-Uptake | 50 mg | 459 |
F-155 | A Blocker of KV4.3 Channels and a Competitive Inhibitor of 5-HT Re-Uptake | 100 mg | 629 |
F-155 | A Blocker of KV4.3 Channels and a Competitive Inhibitor of 5-HT Re-Uptake | 250 mg | 1139 |
F-155 | A Blocker of KV4.3 Channels and a Competitive Inhibitor of 5-HT Re-Uptake | 500 mg | 1479 |
F-160 | An Opener of L-type Ca2+ Channels | 5 mg | 799 |
Alomone中国代理,Alomone上海代理,Alomone北京代理,Alomone广东代理,Alomone江苏代理Alomone湖北代理,Alomone天津代理,Alomone黑龙江代理,Alomone湖南代理Alomone内蒙古代理,Alomone吉林代理,Alomone福建代理,Alomone江苏代理,Alomone浙江代理,Alomone四川代理,Alomone代理,
电话
QQ咨询
4006551678